Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom

FIELD OF THE INVENTION

[0002] The present invention relates to ligands, complexes, compositions and/or catalysts that provide enhanced olefin polymerization capabilities. The catalysts are based on bridged bi-aromatic ligands and metal precursor compositions and/or metal complexes including such ligands combined with activators (or co-catalysts). The invention also relates to methods of polymerization, and in particular to a high-activity solution polymerization process. The invention also relates to novel polymers and their preparation based on the use of these novel catalysts, including isotactic polypropylene and methods of preparing isotactic polypropylene.

BACKGROUND OF THE INVENTION

[0003] Ancillary (or spectator) ligand-metal coordination complexes (e.g., organometallic complexes) and compositions are useful as catalysts, additives, stoichiometric reagents, monomers, solid-state precursors, therapeutic reagents and drugs. Ancillary ligand-metal coordination complexes of this type can be prepared by combining an ancillary ligand with a suitable metal compound or metal precursor in a suitable solvent at a suitable temperature. The ancillary ligand contains functional groups that bind to the metal center(s), remain associated with the metal center(s), and therefore provide an opportunity to modify the steric, electronic and chemical properties of the active metal center(s) of the complex.

[0004] Certain known ancillary ligand-metal complexes and compositions are catalysts for reactions such as oxidation, reduction, hydrogenation, hydrosilylation, hydrocyanation, hydroformylation, polymerization, carbonylation, isomerization, metathesis, carbon-hydrogen activation, carbon-halogen activation, cross-coupling, Friedel-Crafts acylation and alkylation, hydration, dimerization, trimerization, oligomerization, Diels-Alder reactions and other transformations.

[0005] One example of the use of these types of ancillary ligand-metal complexes and compositions is in the field of polymerization catalysis. In connection with single site catalysis, the ancillary ligand typically offers opportunities to modify the electronic and/or steric environment surrounding an active metal center. This allows the ancillary ligand to assist in the creation of possibly different polymers. Group 4 metallocene based single site catalysts are generally known for polymerization reactions. See, generally, “Chemistry of Cationic Dicyclopentadienyl Group 4 Metal-Alkyl Complexes”, Jordan, Adv. Organometallic Chem., 1991, Vol. 32, pp. 325-153 and the references therein, all of which is incorporated herein by reference.

[0006] One application for metallocene catalysts is producing isotactic polypropylene. An extensive body of scientific literature examines catalyst structures, mechanism and polymers prepared by metallocene catalysts. See, e.g., Resconi et al., “Selectivity in Propene Polymerization with Metallocene Catalysts,” Chem. Rev. 2000, 100, 1253-1345 and G. W. Coates, “Precise Control of Polyolefin Stereochemistry Using Single-Site Metal Catalysts,” Chem. Rev. 2000, 100, 1223-1252 and the references sited in these review articles. Isotactic polypropylene has historically been produced with heterogeneous catalysts that may be described as a catalyst on a solid support (e.g., titanium tetrachloride and aluminum alkyls on magnesium dichloride). This process typically uses hydrogen to control the molecular weight and electron-donor compounds to control the isotacticity. See also EP 0 622 380, EP 0 292 134 and U.S. Pat. Nos. 4,971,936, 5,093,415, 4,297,465, 5,385,993 and 6,239,236.

[0007] Given the extensive research activities with respect to metallocene catalysts, there is continued interested in the next generation of non-cyclopentadienyl ligands for olefin polymerization catalysts providing attractive alternatives. See, e.g., “The Search for New-Generation Olefin Polymerization Catalysts: Life beyond Metallocenes”, Gibson, et al., Angew. Chem. Int. Ed., 1999, vol. 38, pp. 428-447; Organometallics 1999, 18, pp. 3649-3670 and “Advances in Non-Metallocene Olefin polymerization Catalysts”, Gibson, et al., Chem Rev. 2003, 103, 283-315. Recently, for isotactic polypropylene, bis-amide catalysts have been disclosed in U.S. Pat. No. 5,318,935 and amidinate catalysts have been disclosed in WO 99/05186. See also U.S. Pat. No. 6,214,939 for non-metallocene isotactic polypropylene catalysts.

[0008] Isotactic polypropylene and its production has been extensively studied. See, e.g., U.S. Pat. No. 6,262,199 for isotactic polypropylene produced with metallocene catalysts. In general, those of skill in the art have concentrated on C2 symmetrical metal complexes based on the theory that such symmetry allows for tacticity control. See, e.g., “Stereospecific Olefin Polymerization with Chiral Metallocene Catalysts”, Brintzinger, et al., Angew. Chem. Int. Ed. Engl., 1995, Vol. 34, pp. 1143-1170. For example, Kol et al., J. Am. Chem. Soc. 2000, 122, 10706-10707 and WO 02/36638 disclose a C2-symmetrical structure that may induce tacticity control. However, the art still fails to provide a higher molecular-weight, narrow polydispersity, isotactic polypropylene with a high melting point, in part provided by an isotactic polypropylene having few, if any, regio-errors (or regio-irregularities), produced at high temperatures (e.g., greater than 100° C.) that is commercially desirable.

[0009] Therefore, a need exists for the discovery and optimization of non-cyclopentadienyl based catalysts for olefin polymerization, and in particular for certain polymers, such as isotactic polypropylene and ethylene-alpha-olefin copolymers. Furthermore, a need still exists for new catalysts to produce high molecular weight isotactic polypropylene with a high melting point, particularly in a solution process and at higher polymerization temperatures.

SUMMARY OF THE INVENTION

[0010] This invention provides a resolution to these needs. This invention discloses enhanced catalytic performances for olefin polymerization when certain ligands are employed in a catalyst, where the ligands are dianionic chelating ligands that can occupy up to four coordination sites of a metal atom and more specifically have a bridged-bis-bi-aryl structure. In addition, some of the ligands, metal complexes and polymers disclosed herein are themselves novel.

[0011] This invention discloses catalysts, compositions and complexes (including activated complexes) based on certain bridged bis-bi-aromatic ancillary ligands. For example, the compositions of this invention comprise a ligand and a metal precursor and optionally an activator. In some embodiments, the ligands and the method of making the ligands is also part of this invention.

[0012] The catalysts in some embodiments are compositions comprising the ligand and metal precursor, and optionally may additionally include an activator, combination of activators or activator package. In other embodiments, the catalysts are metal-ligand complexes and optionally may additionally include an activator, combination of activators or activator package. For example, the metal-ligand complexes of this invention can be characterized by the general formula:

(4,2,O,S)MLn′ (VI)

[0013] where 4,2,O,S) is a dianionic ligand having at least 4 atoms that are oxygen or sulfur and chelating to the metal M at at least 2, more specifically 4, coordination sites through oxygen and/or sulfur atoms; M is a metal selected from the group consisting of groups 3-6 and Lanthanide elements of the Periodic Table of Elements, more specifically, from group 4 (Hf, Zr and Ti); L is independently selected from the group consisting of halide (F, Cl, Br, I), optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, alkylthio, arylthio, nitro, hydrido, allyl, diene, phosphine, carboxylates, 1,3-dionates, oxalates, carbonates, nitrates, sulphates, ethers, thioethers and combinations thereof; and optionally two or more L groups may be linked together in a ring structure; n′ is 1, 2, 3, or 4.

[0014] In another aspect of the invention, a polymerization process is disclosed for monomers. The polymerization process involves subjecting one or more monomers to the catalyst compositions or complexes of this invention under polymerization conditions. The polymerization process can be continuous, batch or semi-batch and can be homogeneous, supported homogeneous or heterogeneous. Another aspect of this invention relates to arrays of ligands, metal precursors and/or metal-ligand complexes. These arrays are useful for the high speed or combinatorial materials science discovery or optimization of the catalyst compositions or complexes disclosed herein.

[0015] In particular, a method of producing isotactic polypropylene in a solution process is disclosed and is surprisingly tunable based on the polymerization conditions, activators and substituents on the catalyst. Other polymerization processes that are tunable based on the same criteria are the copolymerization of ethylene and styrene (or substituted styrene) and ethylene and other alpha-olefins with high incorporation of styrene or the alpha-olefin.

[0016] Thus, it is an object of this invention to polymerize olefins and unsaturated monomers using metal-ligand complexes. It is also an object of this invention to polymerize olefins and unsaturated monomers using compositions including certain bridged bis-aromatic ligands and metal precursors and/or bridged bis-aromatic ligand-metal complexes.

[0017] It is still a further object of this invention to polymerize olefins and unsaturated monomers with the metal-ligand complexes that additionally comprise an activator or combination of activators.

[0018] It is also an object of this invention to use non-metallocene group 4 complexes as polymerization catalysts for the production of isotactic polypropylene or other polymers.

[0019] Further objects and aspects of this invention will be evident to those of skill in the art upon review of this specification.

BRIEF DESCRIPTION OF THE DRAWINGS

[0020]

FIG. 1

a
is an X-ray crystal structure of the compound identified herein as C5 and FIG. 1b is an alternate view of the same crystal structure.

[0021]
FIG. 2, including parts A, B, C and D, is a spectrum comparing various isotactic polypropylene polymers made in accord with this invention, some with regio-errors and others without detectible regio-errors.

DETAILED DESCRIPTION OF THE INVENTION

[0022] As used herein, the phrase “characterized by the formula” is not intended to be limiting and is used in the same way that “comprising” is commonly used. The term “independently selected” is used herein to indicate that the R groups, e.g., R1, R2, R3, R4, and R5 can be identical or different (e.g. R1, R2, R3, R4, and R5 may all be substituted alkyls or R1 and R2 may be a substituted alkyl and R3 may be an aryl, etc.). Use of the singular includes use of the plural and vice versa (e.g., a hexane solvent, includes hexanes). A named R group will generally have the structure that is recognized in the art as corresponding to R groups having that name. The terms “compound” and “complex” are generally used interchangeably in this specification, but those of skill in the art may recognize certain compounds as complexes and vice versa. For the purposes of illustration, representative certain groups are defined herein. These definitions are intended to supplement and illustrate, not preclude, the definitions known to those of skill in the art.

[0023] “Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not. For example, the phrase “optionally substituted hydrocarbyl” means that a hydrocarbyl moiety may or may not be substituted and that the description includes both unsubstituted hydrocarbyl and hydrocarbyl where there is substitution.

[0024] The term “alkyl” as used herein refers to a branched or unbranched saturated hydrocarbon group typically although not necessarily containing 1 to about 50 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, octyl, decyl, and the like, as well as cycloalkyl groups such as cyclopentyl, cyclohexyl and the like. Generally, although again not necessarily, alkyl groups herein may contain 1 to about 12 carbon atoms. The term “lower alkyl” intends an alkyl group of one to six carbon atoms, specifically one to four carbon atoms. “Substituted alkyl” refers to alkyl substituted with one or more substituent groups (e.g., benzyl or chloromethyl), and the terms “heteroatom-containing alkyl” and “heteroalkyl” refer to alkyl in which at least one carbon atom is replaced with a heteroatom (e.g., —CH2OCH3 is an example of a heteroalkyl).

[0025] The term “alkenyl” as used herein refers to a branched or unbranched hydrocarbon group typically although not necessarily containing 2 to about 50 carbon atoms and at least one double bond, such as ethenyl, n-propenyl, isopropenyl, n-butenyl, isobutenyl, octenyl, decenyl, and the like. Generally, although again not necessarily, alkenyl groups herein contain 2 to about 12 carbon atoms. The term “lower alkenyl” intends an alkenyl group of two to six carbon atoms, specifically two to four carbon atoms. “Substituted alkenyl” refers to alkenyl substituted with one or more substituent groups, and the terms “heteroatom-containing alkenyl” and “heteroalkenyl” refer to alkenyl in which at least one carbon atom is replaced with a heteroatom.

[0026] The term “alkynyl” as used herein refers to a branched or unbranched hydrocarbon group typically although not necessarily containing 2 to about 50 carbon atoms and at least one triple bond, such as ethynyl, n-propynyl, isopropynyl, n-butynyl, isobutynyl, octynyl, decynyl, and the like. Generally, although again not necessarily, alkynyl groups herein may have 2 to about 12 carbon atoms. The term “lower alkynyl” intends an alkynyl group of two to six carbon atoms, specifically three or four carbon atoms. “Substituted alkynyl” refers to alkynyl substituted with one or more substituent groups, and the terms “heteroatom-containing alkynyl” and “heteroalkynyl” refer to alkynyl in which at least one carbon atom is replaced with a heteroatom.

[0027] The term “alkoxy” as used herein intends an alkyl group bound through a single, terminal ether linkage; that is, an “alkoxy” group may be represented as —O-alkyl where alkyl is as defined above. A “lower alkoxy” group intends an alkoxy group having one to six, more specifically one to four, carbon atoms. The term “aryloxy” is used in a similar fashion, with aryl as defined below. The term “hydroxy” refers to —OH.

[0028] Similarly, the term “alkylthio” as used herein intends an alkyl group bound through a single, terminal thioether linkage; that is, an “alkylthio” group may be represented as —S-alkyl where alkyl is as defined above. A “lower alkyl thio” group intends an alkyl thio group having one to six, more specifically one to four, carbon atoms. The term “arylthio” is used similarly, with aryl as defined below. The term “thioxy” refers to —SH.

[0029] The term “allenyl” is used herein in the conventional sense to refer to a molecular segment having the structure —CH═C═CH2. An “allenyl” group may be unsubstituted or substituted with one or more non-hydrogen substituents.

[0030] The term “aryl” as used herein, and unless otherwise specified, refers to an aromatic substituent containing a single aromatic ring or multiple aromatic rings that are fused together, linked covalently, or linked to a common group such as a methylene or ethylene moiety. More specific aryl groups contain one aromatic ring or two or three fused or linked aromatic rings, e.g., phenyl, naphthyl, biphenyl, anthracenyl, phenanthrenyl, and the like. In particular embodiments, aryl substituents have 1 to about 200 carbon atoms, typically 1 to about 50 carbon atoms, and specifically 1 to about 20 carbon atoms. “Substituted aryl” refers to an aryl moiety substituted with one or more substituent groups, (e.g., tolyl, mesityl and perfluorophenyl) and the terms “heteroatom-containing aryl” and “heteroaryl” refer to aryl in which at least one carbon atom is replaced with a heteroatom (e.g., rings such as thiophene, pyridine, isoxazole, pyrazole, pyrrole, furan, etc. or benzo-fused analogues of these rings are included in the term “heteroaryl”). In some embodiments herein, multi-ring moieties are substituents and in such an embodiment the multi-ring moiety can be attached at an appropriate atom. For example, “naphthyl” can be 1-naphthyl or 2-naphthyl; “anthracenyl” can be 1-anthracenyl, 2-anthracenyl or 9-anthracenyl; and “phenanthrenyl” can be 1-phenanthrenyl, 2-phenanthrenyl, 3-phenanthrenyl, 4-phenanthrenyl or 9-phenanthrenyl.

[0031] The term “aralkyl” refers to an alkyl group with an aryl substituent, and the term “aralkylene” refers to an alkylene group with an aryl substituent; the term “alkaryl” refers to an aryl group that has an alkyl substituent, and the term “alkarylene” refers to an arylene group with an alkyl substituent.

[0032] The terms “halo” and “halogen” are used in the conventional sense to refer to a chloro, bromo, fluoro or iodo substituent. The terms “haloalkyl,” “haloalkenyl” or “haloalkynyl” (or “halogenated alkyl,” “halogenated alkenyl,” or “halogenated alkynyl”) refers to an alkyl, alkenyl or alkynyl group, respectively, in which at least one of the hydrogen atoms in the group has been replaced with a halogen atom.

[0033] The term “heteroatom-containing” as in a “heteroatom-containing hydrocarbyl group” refers to a molecule or molecular fragment in which one or more carbon atoms is replaced with an atom other than carbon, e.g., nitrogen, oxygen, sulfur, phosphorus, boron or silicon. Similarly, the term “heteroalkyl” refers to an alkyl substituent that is heteroatom-containing, the term “heterocyclic” refers to a cyclic substituent that is heteroatom-containing, the term “heteroaryl” refers to an aryl substituent that is heteroatom-containing, and the like. When the term “heteroatom-containing” appears prior to a list of possible heteroatom-containing groups, it is intended that the term apply to every member of that group. That is, the phrase “heteroatom-containing alkyl, alkenyl and alkynyl” is to be interpreted as “heteroatom-containing alkyl, heteroatom-containing alkenyl and heteroatom-containing alkynyl.”

[0034] “Hydrocarbyl” refers to hydrocarbyl radicals containing 1 to about 50 carbon atoms, specifically 1 to about 24 carbon atoms, most specifically 1 to about 16 carbon atoms, including branched or unbranched, saturated or unsaturated species, such as alkyl groups, alkenyl groups, aryl groups, and the like. The term “lower hydrocarbyl” intends a hydrocarbyl group of one to six carbon atoms, specifically one to four carbon atoms. “Substituted hydrocarbyl” refers to hydrocarbyl substituted with one or more substituent groups, and the terms “heteroatom-containing hydrocarbyl” and “heterohydrocarbyl” refer to hydrocarbyl in which at least one carbon atom is replaced with a heteroatom.

[0035] By “substituted” as in “substituted hydrocarbyl,” “substituted aryl,” “substituted alkyl,” “substituted alkenyl” and the like, as alluded to in some of the aforementioned definitions, is meant that in the hydrocarbyl, hydrocarbylene, alkyl, alkenyl, aryl or other moiety, at least one hydrogen atom bound to a carbon atom is replaced with one or more substituents that are functional groups such as hydroxyl, alkoxy, alkylthio, phosphino, amino, halo, silyl, and the like. When the term “substituted” appears prior to a list of possible substituted groups, it is intended that the term apply to every member of that group. That is, the phrase “substituted alkyl, alkenyl and alkynyl” is to be interpreted as “substituted alkyl, substituted alkenyl and substituted alkynyl.” Similarly, “optionally substituted alkyl, alkenyl and alkynyl” is to be interpreted as “optionally substituted alkyl, optionally substituted alkenyl and optionally substituted alkynyl.”

[0036] By “divalent” as in “divalent hydrocarbyl”, “divalent alkyl”, “divalent aryl” and the like, is meant that the hydrocarbyl, alkyl, aryl or other moiety is bonded at two points to atoms, molecules or moieties with the two bonding points being covalent bonds. The term “aromatic” is used in its usual sense, including unsaturation that is essentially delocalized across multple bonds, such as around a ring.

[0037] As used herein the term “silyl” refers to the —SiZ1Z2Z3 radical, where each of Z1, Z2, and Z3 is independently selected from the group consisting of hydride and optionally substituted alkyl, alkenyl, alkynyl, heteroatom-containing alkyl, heteroatom-containing alkenyl, heteroatom-containing alkynyl, aryl, heteroaryl, alkoxy, aryloxy, amino, silyl and combinations thereof.

[0038] As used herein the term “boryl” refers to the —BZ1Z2 group, where each of Z1 and Z2 is as defined above. As used herein, the term “phosphino” refers to the group —PZ1Z2, where each of Z1 and Z2 is as defined above. As used herein, the term “phosphine” refers to the group: PZ1Z2Z3, where each of Z1, Z3 and Z2 is as defined above. The term “amino” is used herein to refer to the group —NZ1Z2, where each of Z1 and Z2 is as defined above. The term “amine” is used herein to refer to the group: NZ1Z2Z3, where each of Z1, Z2 and Z3 is as defined above.

[0039] The term “saturated” refers to lack of double and triple bonds between atoms of a radical group such as ethyl, cyclohexyl, pyrrolidinyl, and the like. The term “unsaturated” refers to the presence of one or more double and triple bonds between atoms of a radical group such as vinyl, acetylide, oxazolinyl, cyclohexenyl, acetyl and the like.

[0040] Other abbreviations used herein include: “iPr” to refer to isopropyl; “tBu” to refer to tertbutyl; “Me” to refer to methyl; “Et” to refer to ethyl; and “Ph” refers to phenyl.

[0041] The ligands that are suitable for use in the catalysts herein have several general, alternative descriptions. In one embodiment, the ligands are dianionic, chelating ligands that may occupy up to four coordination sites of a metal atom. The ligands can also be described as diaionic ligands that, when chelated to a metal atom, form at least one or two seven member metalocycles (counting the metal atom as one member of the seven member ring). Also, in some embodiments, the ligands can be described as dianionic, chelating ligands that use either oxygen or sulfur as binding atoms to the metal atom. In still other embodiments, the ligands can be described as non-metallocene ligands that can coordinate in an approximate C2-symmetcial complex with a metal atom. These embodiments can be used together or separately.

[0042] For example, suitable ligands useful in this invention may be characterized by the following general formulas:

[0043] wherein each ligand has at least two hydrogen atoms capable of removal in a binding reaction with a metal atom or metal precursor or base; AR is an aromatic group that can be the same or different from the other AR groups with, generally, each AR being independently selected from the group consisting of optionally substituted aryl or heteroaryl; B is a bridging group having from one to 50 atoms (not counting hydrogen atoms); X and X′ are the same or different and are independently selected from the group consisting of oxygen, sulfur, —NR30—, —PR30—, where R30 is selected from the group consisting of hydride, halide, and optionally substituted hydrocarbyl, heteroatom-containing hydrocarbyl, silyl, boryl, alkoxy, aryloxy and combinations thereof; X″ and X′″ are the same or different and are independently selected from the group consisting of optionally substituted amino, phosphino, hydroxy, alkoxy, aryloxy, thioxy, alkylthio and arylthio; Y and Y′ are the same or different and are independently selected from the group consisting of optionally substituted amino, phosphino, hydroxy, alkoxy, aryloxy, thioxy, alkylthio and arylthio; when the AR group attached to the bridge is an optionally substituted heteroaryl, X and/or X′ can be part of the aromatic ring. The difference between formulas I and II are that the bridge is either directly attached to the aromatic ring (formula II) or is attached to the aromatic ring via the X and/or X′ group (formula I).

[0044] In formula I and formula II, it is required that there be at least 2 hydrogen atoms associated with each ligand that are capable of being removed in a complexation reaction with a metal atom or metal precursor or base. In some embodiments, prior to such a complexation reaction, a base may be reacted with the ligand to form a salt, the product of which may then be reacted with a metal precursor (as described herein). In some embodiments at least two of X, X′, Y and Y′ or at least two of X″, X′″, Y and Y′ have at least one hydrogen atom. In some embodiments, R30 is selected from the group consisting of hydride and optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, halide, nitro, and combinations thereof. In some embodiments, X and X′ are independently selected from the group consisting of oxygen, sulfur and —NR30—; and in still other embodiments X and X′ are independently selected from the group consisting of oxygen and sulfur. In some embodiments, Y and Y′ are selected from the group consisting of amino, hydroxy, alkoxy, aryloxy, thioxy, alkylthio and arylthio; and in still other embodiments Y and Y′ are independently selected from the group consisting of hydroxy and thioxy.

[0045] Generally, the “upper aromatic ring” is the ring to which a Y group (such as Y, Y′) is bonded or part of. Similarly, the “lower aromatic ring” is the ring to which an X group (such as X, X′, X″, etc.) is bonded or part of. In some embodiments, at least one AR is a heteroaromatic and more specifically a heteroaryl group. In other embodiments, at least one upper aromatic ring is a heteroaromatic and more specifically a heteroaryl. Other embodiments include those where at least one lower aromatic ring is a heteroaromatic and more specifically a heteroaryl.

[0046] In some embodiments, the bridging group B is selected from the group consisting of optionally substituted divalent hydrocarbyl and divalent heteroatom containing hydrocarbyl. In other embodiments, B is selected from the group consisting of optionally substituted divalent alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl and silyl. In still other embodiments, B can be represented by the general formula —(Q″R402−z″)z′— wherein each Q″ is either carbon or silicon and each R40 may be the same or different from the others such that each R40 is selected from the group consisting of hydride and optionally substituted hydrocarbyl, and optionally two or more R40 groups may be joined into a ring structure having from 3 to 50 atoms in the ring structure (not counting hydrogen atoms); and z′ is an integer from 1 to 10, more specifically from 1-5 and even more specifically from 2-5 and z″ is 0, 1 or 2. For example, when z″ is 2, there is no R40 groups associated with Q″, which allows for those cases where one Q″ is multiply bonded to a second Q″. In more specific embodiments, R40 is selected from the group consisting of hydride, halide, and optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, and combinations thereof. Specific B groups within these embodiments include —(CH2)2—, —(CH2)3—, —(CH2)4—, and —(CH2)—(C6H4)—(CH2)—. Other specific bridging moieties are set forth in the example ligands and complexes herein.

[0047] In other embodiments, the ligands can be characterized by the general formula:

[0048] wherein each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, and R20 is independently selected from the group consisting of hydride, halide, and optionally substituted hydrocarbyl, heteroatom-containing hydrocarbyl, alkoxy, aryloxy, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, nitro, and combinations thereof; optionally two or more R groups can combine together into ring structures (for example, single ring or multiple ring structures), with such ring structures having from 3 to 12 atoms in the ring (not counting hydrogen atoms); B is a bridging group having from one to 50 atoms (not counting hydrogen atoms); X and X′ and Y and Y′ are as defined above. The notation —Y, —Y′, —X and —X′ is intended to mean that the group can be part of the aromatic ring (forming a heteroaryl) and/or replace one or more of the R groups (R1-R20). The notation for the bridging group B (∪B∪) can be combined with either or both —X and —X′ or the bridging group can replace one or more of the R groups on the indictated structure (e.g., such as R9 and/or R19). In those embodiments where the bridging group B is not combined with the —X and/or —X′ group, X and X′ are defined as X″ and X′″, above.

[0049] In more specific embodiments, each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, and R20 is independently selected from the group consisting of hydride, halide, and optionally substituted alkyl, heteroalkyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, nitro, and combinations thereof. In even more specific embodiments, each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19 and R20 is independently selected from the group consisting of hydride, halide, and optionally substituted alkyl, heteroalkyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, amino, alkylthio and arylthio. In some embodiments, at least one of R2 and R12 is not hydrogen and in still other embodiments both R2 and R12 are not hydrogen.

[0050] In more specific embodiments, the ligands useful in this invention can be characterized by the formula:

[0051] wherein R2, R3, R4, R5, R6, R7, R8, R9, R12, R13, R14, R15, R16, R17, R18, and R19 are as defined above, B is as defined above, X and X′ are as defined above, and Y and Y′ are as defined above with the proviso that each of Y and Y′ include hydrogen.

[0052] In more specific embodiments, the ligands useful in this invention can be characterized by the formula:

[0053] In formula (V), the bridging group has been made part of the X moieties and the bis-aryl moieties have been made the same as each other. The Y moieties again include hydrogen. In addition, in formula (V), each of R2, R3, R4, R5, R6, R7, R8 and R9 is independently selected from the group consisting of hydride, halide, and optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio and arylthio, nitro, and combinations thereof.

[0054] Specific ligands within the scope of this invention include:

[0055] In some embodiments the choice of X, X′, Y, Y′, R2, R12 and B have a strong influence on the production of isotactic polypropylene in a solution process. Specific ligands within the scope of this particularization include for example: LL1-LL10, LL12-LL23, LL26-LL32, LL37-LL40, LL45-LL49 and LL52-LL57.

[0056] In some embodiments, the size and identity of the substituents on the AR—Y and AR—Y′, such as the R2 and/or R12 groups, has an influence on the production of isotactic polypropylene in a solution process, allowing for a range of isotactic polypropylene polymers to be prepared with desired properties. Thus, in such embodiments, R2 and R12 are bulky substituents and may be independently selected from the group consisting of optionally substituted cycloalkylaryl, aryl and heteroaryl. More specifically, each R2 and/or R12 is independently selected from the group consisting of optionally substituted aryl and heteroaryl. Specific R2 and/or R12 groups include carbozole, 3,5-bis-tert-butyl-phenyl, 1,2,3,4,5,6,7,8-octahydroanthacenyl, 1-naphthyl, 9-anthracenyl and 2,4,6-trimethylphenyl. Specific ligands within the scope of this particularization for bulky substituents include:

[0057] In some embodiments, the size and identity of the substituents on the upper aromatic ring (e.g., AR—X and AR—X′), such as the R7 and/or R17 groups, has an influence on the production of isotactic polypropylene in a solution process, allowing for a range of isotactic polypropylene polymers to be prepared with desired properties. Thus, in such embodiments, R7 and R17 may be independently selected from the group consisting of halo and optionally substituted hydrocarbyl, alkoxy, aryloxy, dialkyl- or diarylamino, alkyl or arylthio. Similarly in such embodiments, R4 and R14 may be independently selected from the group consisting of halo and optionally substituted hydrocarbyl, alkoxy, aryloxy, dialkyl- or diarylamino, alkyl- or arylthio. Specific ligands within the scope of this particularization include:

[0058] Certain of the ligands are novel compounds and those of skill in the art will be able to identify such compounds from the above. Also, certain embodiments of these ligands are preferred for the polymerization of certain monomers in a catalytic composition and/or in a metal complex. These certain embodiments are discussed further below.

[0059] In some embodiments, the ligands of the invention may be prepared using known procedures. See, for example, Advanced Organic Chemistry, March, Wiley, New York 1992 (4th Ed.). Specifically, the ligands of the invention may be prepared using a variety of synthesis routes, depending on the variation desired in the ligand. In general, building blocks are prepared that are then linked together with a bridging group. Variations in the R group substituents can be introduced in the synthesis of the building blocks. Variations in the bridge can be introduced with the synthesis of the bridging group.

[0060] Specific ligands within the scope of this invention may be prepared according to the general schemes shown below, where building blocks (designated BB) are first prepared and then coupled together. There are several different ways to use these building blocks. In one embodiment, generally, each of the optionally substituted phenyl rings is prepared as a separate building block (schemes 1 (a and b) and 2). The desired optionally substituted phenyls are then combined into bi-phenyl building blocks (schemes 3 and 4), which are then bridged together (schemes 7, 8, 9, and 10). In another embodiment, the optionally substituted phenyl building blocks are bridged together (schemes 5 and 6) and then additional optionally substituted phenyl building blocks are added to form the bridged bi-aryl structures (schemes 11, 12, 13, and 14). In addition, schemes to effect certain substitutions on the phenyl groups are included (schemes 15, 16, 17 and 18). In many of these schemes, cross coupling reactions are used (e.g., Suzuki, Negishi or Buchwald-Hartwig cross coupling). These cross coupling reactions are generally known in the art; for example, see Tetrahedron, 1998, 54(3/4), 263-303 and J. Am. Chem. Soc. 2001, 123(31), 7727-7729. The starting materials or reagents used in these schemes are generally commercially available, or are prepared via routine synthetic means.

[0061] To facilitate the description of the ligand synthesis techniques used, following are some abbreviations that are used in this description (including the schemes): PG=“protecting group”, which typically means a phenol or thiophenol protecting group including, but not limited to: methyl (Me), benzyl (Bn), substituted benzyl (2-methoxyphenylmethyl: MPM, etc.), alkoxymethyl (methoxymethyl: MOM, etc.), tetrahydropyranyl (THP), silyl (trimethylsilyl: TMS, tert-butyldimethylsilyl: TBS, etc.) and allyl (Allyl); LG=“leaving group”=leaving group for nucleophilic displacement reactions group including, but not limited to: chloro, bromo, iodo, tosyl (para-toluenesulfonyl) and triflic (trifluoromethylsulfonyl). The symbol

[0062] depicts a bridging moiety as defined elsewhere in this specification. The term “upper phenyl ring” is used consistently with the term “upper aromatic ring”, described above. The term “lower phenyl ring” is used consistently with the term “lower aromatic ring”, described above.

[0063] Scheme 1 a below is a general building block synthesis scheme, specifically depicting the synthesis of Y-protected, 2-bromo substituted, upper phenyl ring building blocks:

[0064] As shown in Scheme 1a, a protecting group (PG) is used to prepare the appropriate building block (BB(a)). The substituents on the building block are as defined above. The variables R and R′ are generally selected from the same group as R2, and may be optionally substituted alkyl, aryl, amino and the like; optionally R and R′ may be linked or fused. “Appropriate cross-coupling reaction conditions” are generally known to those of skill in the art, and may be found in the above-cited references. Other reaction conditions will be known to those of skill in the art, with reference to the examples herein.

[0065] As an alternative, Scheme 1b shows a general synthesis scheme for Y-protected, 2-bromo substituted, upper phenyl ring building blocks:

[0066] In scheme 1b, the variables are defined as discussed above.

[0067] Scheme 2 below is a general scheme for the synthesis of X-protected 2-boronic ester substituted lower phenyl ring building blocks, X-protected 2-ZnCl substituted lower-ring building blocks, and X-deprotected 2-boronic acid substituted lower ring building blocks:

[0068] In scheme 2, the variables are defined as discussed above. In addition the phrase “cat. H+” refers to an acid catalyzed reaction that supplies a hydrogen ion, such as p-toluenesufonic acid (TsOH) or hydrochloric acid (HCl), as is known to those of skill in the art.

[0069] Scheme 3 below is a general scheme for the synthesis of Y-protected upper phenyl ring, X-deprotected lower phenyl ring building block:

[0070] In scheme 3, the variables are defined as discussed above.

[0071] Scheme 4 below is a general scheme for the synthesis of 2-bromo substituted, Y-protected upper phenyl ring, X-deprotected lower phenyl ring building block:

[0072] In scheme 4, the variables are defined as discussed above.

[0073] Scheme 5 below is a general scheme for the synthesis of symmetric 2-Br substituted, 2-boronic ester-substituted and 2-ZnCl-substituted, bridged lower phenyl ring building blocks:

[0074] In scheme 5, the variables are defined as discussed above. In addition the phrase “base” refers to bases in general (such as cesium carbonate or potassium tert-butoxide), as is known to those of skill in the art. Also the phrase “cat. Pd(0)” refers to a catalyst that uses a ligand-stabilized Pd0 complex, known to those of skill in the art.

[0075] Scheme 6 below is a general scheme for the synthesis of unsymmetric 2-Br substituted, 2-boronic ester-substituted and 2-ZnCl-substituted, bridged lower phenyl ring building blocks:

[0076] In scheme 6, the variables are defined as discussed above.

[0077] Scheme 7 below is a general scheme for the synthesis of symmetric Y-protected, upper phenyl ring 2-bromo-substituted, lower phenyl ring bridged building blocks:

[0078] In scheme 7, the variables are defined as discussed above.

[0079] Scheme 8 below is a general scheme for the synthesis of unsymmetric Y,Y′-protected, upper phenyl ring 2-bromo-substituted, lower phenyl ring bridged building blocks:

[0080] In scheme 8, the variables are defined as discussed above.

[0081] Scheme 9 below is a general scheme for the double reaction of building block BB(e) with bridge, followed by deprotection:

[0082] In scheme 9, the variables are defined as discussed above.

[0083] Scheme 10 below is a general scheme for the sequential reaction of building blocks BB(e) and BB(f) with bridge, followed by deprotection:

[0084] In scheme 10, the variables are defined as discussed above.

[0085] Scheme 11 below is a general scheme for the conversion of building block BB(a) to a boronic ester or ZnCl derivative, followed by double cross-coupling with building block BB(g) and subsequent deprotection:

[0086] In scheme 11, the variables are defined as discussed above.

[0087] Scheme 12 below is a general scheme for the conversion of building block BB(a) to a boronic ester or ZnCl derivative, followed by double cross-coupling with building block BB(j) and subsequent deprotection:

[0088] In scheme 12, the variables are defined as discussed above.

[0089] Scheme 13 below is a general scheme for the double cross-coupling of building blocks BB(h) or BB(i) with building block BB(a), followed by deprotection:

[0090] In scheme 13, the variables are defined as discussed above.

[0091] Scheme 14 below is a general scheme for the double cross-coupling of building blocks BB(k) or BB(l) with building block BB(a), followed by deprotection:

[0092] In scheme 14, the variables are defined as discussed above.

[0093] Scheme 15 below is a general scheme for the double cross-coupling of building block BB(m), followed by deprotection:

[0094] In scheme 15, the variables are defined as discussed above.

[0095] Scheme 16 below is a general scheme for the double cross-coupling of building block BB(n), followed by deprotection:

[0096] In scheme 16, the variables are defined as discussed above.

[0097] Scheme 17 below is a general scheme for the conversion of building block BB(m) into a B(OR)2 or ZnX derivative, followed by double cross-coupling and deprotection:

[0098] Scheme 18 below is a general scheme for the conversion of building block BB(n) into a B(OR)2 or ZnX derivative, followed by double cross-coupling and deprotection:

[0099] Once the desired ligand is formed, it may be combined with a metal atom, ion, compound or other metal precursor compound. For example, in some embodiments, the metal precursors are activated metal precursors, which refers to a metal precursor (described below) that has been combined or reacted with an activator (described below) prior to combination or reaction with the ancillary ligand. In some applications, the ligands of this invention will be combined with a metal compound or precursor and the product of such combination is not determined, if a product forms. For example, the ligand may be added to a reaction vessel at the same time as the metal or metal precursor compound along with the reactants, activators, scavengers, etc. Additionally, the ligand can be modified prior to addition to or after the addition of the metal precursor, e.g. through a deprotonation reaction or some other modification.

[0100] For formulas I, II, III, IV and V, the metal precursor compounds may be characterized by the general formula M(L)n where M is a metal selected from the group consisting of groups 3-6 and Lanthanide elements of the Periodic Table of Elements, more specifically, from group 4 (Hf, Zr and Ti); L is independently selected from the group consisting of halide (F, Cl, Br, I), optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, hydrido, allyl, diene, phosphine, carboxylates, 1,3-dionates, oxalates, carbonates, nitrates, sulphates, ethers, thioethers and combinations thereof; L may also be ionically bonded to the metal M and for example, L may be a non-coordinated or loosely coordinated or weakly coordinated anion (e.g., L may be selected from the group consisting of those anions described below in the conjunction with the activators), see Marks et al., Chem. Rev. 2000, 100, 1391-1434 for a detailed discussion of these weak interactions; and optionally two or more L groups may be linked together in a ring structure. n is 1, 2, 3, 4, 5, or 6. The metal precursors may be monomeric, dimeric or higher orders thereof. Specific examples of suitable titanium, hafnium and zirconium precursors include, but are not limited to TiCl4, Ti(CH2Ph)4, Ti(CH2CMe3)4, Ti(CH2SiMe3)4, Ti(CH2Ph)3Cl, Ti(CH2CMe3)3Cl, Ti(CH2SiMe3)3Cl, Ti(CH2Ph)2Cl2, Ti(CH2CMe3)2Cl2, Ti(CH2SiMe3)2Cl2, Ti(NMe2)4, Ti(NEt2)4, Ti(O-isopropyl)4, and Ti(N(SiMe3)2)2Cl2; HfCl4, Hf(CH2Ph)4, Hf(CH2CMe3)4, Hf(CH2SiMe3)4, Hf(CH2Ph)3Cl, Hf(CH2CMe3)3Cl, Hf(CH2SiMe3)3Cl, Hf(CH2Ph)2Cl2, Hf(CH2CMe3)2Cl2, Hf(CH2SiMe3)2Cl2, Hf(NMe2)4, Hf(NEt2)4, and Hf(N(SiMe3)2)2Cl2; ZrCl4, Zr(CH2Ph)4, Zr(CH2CMe3)4, Zr(CH2SiMe3)4, Zr(CH2Ph)3Cl, Zr(CH2CMe3)3Cl, Zr(CH2SiMe3)3Cl, Zr(CH2Ph)2Cl2, Zr(CH2CMe3)2Cl2, Zr(CH2SiMe3)2Cl2, Zr(NMe2)4, Zr(NEt2)4, Zr(NMe2)2Cl2, Zr(NEt2)2Cl2, and Zr(N(SiMe3)2)2Cl2. Lewis base adducts of these examples are also suitable as metal precursors, for example, ethers, amines, thioethers, phosphines and the like are suitable as Lewis bases. Specific examples include HfCl4(THF)2, HfCl4(SMe2)2 and Hf(CH2Ph)2Cl2(OEt2). Activated metal precursors may be ionic or zwitterionic compounds, such as (M(CH2Ph)3+)(B(C6F5)4−) or (M(CH2Ph)3+)(PhCH2B(C6F5)3−) where M is defined above (and more specifically Hf or Zr). Activated metal precursors or such ionic compounds can be prepared in the manner shown in Pellecchia et al., Organometallics, 1994, 13, 298-302; Pellecchia et al., J. Am. Chem. Soc., 1993, 115, 1160-1162; Pellecchia et al., Organometallics, 1993, 13, 3773-3775 and Bochmann et al., Organometallics, 1993, 12, 633-640, each of which is incorporated herein by reference.

[0101] The ligand to metal precursor compound ratio is typically in the range of about 0.01:1 to about 100:1, more specifically in the range of about 0.1:1 to about 10:1 and even more specifically about 1:1.

[0102] This invention, in part, relates to new metal-ligand complexes. Generally, the ligand is mixed with a suitable metal precursor (and optionally other components, such as activators) prior to or simultaneously with allowing the mixture to be contacted with the reactants (e.g., monomers). When the ligand is mixed with the metal precursor compound, a metal-ligand complex may be formed, which may be a catalyst or may need to be activated to be a catalyst.

[0103] The metal-ligand complexes of this invention can in general be characterized in overlapping or alterative descriptions. In one embodiment, the metal-ligand complexes have dianionic, chelating ligands that may occupy up to four coordination sites of the metal atom. The metal-ligand complexes can also be described as having dianionic ligands that form two seven-member metallocycles with the metal atom (counting the metal atom as one member of the seven member ring). Also, in some embodiments, the metal-ligand complexes can be described as having dianionic, chelating ligands that use oxygen and/or sulfur as binding atoms to the metal atom. In still other embodiments, the metal-ligand complexes can be described as having non-metallocene ligands that can coordinate in an approximate C2 symmetric complex with the metal atom. By approximate C2 symmetry it is meant that coordination of the ligand with the metal may still be considered so that the ligand parts occupy four approximately C2 symmetric quadrants around the metal center extending towards the ligands L and approximate means that true symmetry may not exist due to several factors that effect symmetry, including, for example, the effect of the bridge. In particular, the bulky R2 and/or R12 group the ligand may be approximately C2 symmetrically arranged around the metal center. FIGS. 1a and 1b demonstrate what is meant herein by approximate C2 symmetry. Also, this approximate symmetry can be determined by proton NMR.

[0104] In some embodiments, the metal-ligand complexes of this invention can be characterized by the general formula:

(4,2,O,S)MLn′ (VI)

[0105] where (4,2,O,S) is a dianionic ligand having at least 4 atoms that are each independently oxygen or sulfur and chelating to the metal M at 4 coordination sites through oxygen and/or sulfur atoms with two of the bonds between the oxygen or sulfur atoms and the metal being covelent in nature and two of the bonds being dative in nature (i.e., oxygen or sulfur atoms acting as Lewis bases and the metal center acting as a Lewis acid); M is a metal selected from the group consisting of groups 3-6 and Lanthanide elements of the Periodic Table of Elements, more specifically, from group 4 (Hf, Zr and Ti); L is independently selected from the group consisting of halide (F, Cl, Br, I), optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, nitro, hydrido, allyl, diene, phosphine, carboxylates, 1,3-dionates, oxalates, carbonates, nitrates, sulphates, ethers, thioethers and combinations thereof; and optionally two or more L groups may be linked together in a ring structure; n′ is 1, 2, 3, or 4.

[0106] In other embodiments, the metal-ligand complexes of this invention are those comprising two seven-member metallocycles formed with bonds from the metal atom to at least 2 heteroatoms (e.g., O, S, N, P, Se and the like). In more specific forms, these metal-ligand complexes comprise two seven-member metallocycles and even more specifically, there are at least two seven-member metallocycles that are joined together by at least one bridging group. In still other embodiments, two, bridged seven-member metallocycles form a symmetrical complex. Thus for example, the metal-ligand complex below is one embodiment of this invention:

[0107] where the complex includes two metallocycles bound by a single bridging group.

[0108] In still other embodiments, the metal-ligand complexes of this invention may be characterized by the general formulas:

[0109] wherein each of AR, M, L, B, and n′, are as defined above; and the dotted lines indicate possible binding to the metal atom, provided that at least two of the dotted lines are covalent bonds. X, X′, X4, X5, Y2 and Y3 are derived from the definitions detailed above in that at least two hydrogen atoms are removed from X, X′, X″, X′″, Y and Y′, in a manner known to those of skill in the art, to form the at least two covalent bonds between the X and/or Y moieties and the metal. Depending on the number of covalent bonds, as those of skill in the art can determine, in some embodiments, X and X′ and Y2 and Y3 are the same or different and are independently selected from the group consisting of oxygen, sulfur, —NR30—, and —PR30—, where R30 is selected from the group consisting of hydride, halide, and optionally substituted hydrocarbyl, heteroatom-containing hydrocarbyl, silyl, boryl, alkoxy, aryloxy and combinations thereof. In other embodiments, Y2 and Y3 are the same or different and are independently selected from the group consisting of optionally substituted amino, phosphino, hydroxy, alkoxy, aryloxy, thioxy, alkylthio and arylthio. In some embodiments, X4 and X5 are the same or different and are independently selected from the group consisting of optionally substituted amino, phosphino, hydroxy, alkoxy, aryloxy, thioxy, alkylthio and arylthio, provided that when the bond to the metal is covalent X4 and X5 are independently selected from the group consisting of oxygen, sulfur, —NR30—, and —PR30—. Note also that Ln′ indicates that the metal M is bonded to a number n′ groups of L, as defined above.

[0110] In still other embodiments, the metal-ligand complexes of this invention may be characterized by the general formula:

[0111] wherein each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, M, L, n′, B, X, X′, Y2 and Y3 are as defined above and as further explained in connection which structures (VII) and (VIII). The dotted lines indicate possible binding to the metal atom, provided that at least two of the dotted lines are covalent bonds.

[0112] In still other embodiments, the metal-ligand complexes of this invention may be characterized by the general formula:

[0113] wherein R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, M, L, n′, B, X, X′, Y2 and Y3 are as defined above are as defined above and as further explained in connection which structures (VII) and (VIII). The dotted lines indicate possible binding to the metal atom, provided that at least two of the dotted lines are covalent bonds.

[0114] In more specific embodiments, the the metal-ligand complexes of this invention may be characterized by the general formula:

[0115] wherein R2, R3, R4, R5, R6, R7, R8, R9, M, L, n′, B, X, X′, and Y2 are as defined above are as defined above and as further explained in connection which structures (VII) and (VIII). The dotted lines indicate possible binding to the metal atom, provided that at least two of the dotted lines are covalent bonds. In formula (XI), the metal-ligand complex may also have approximate C2 symmetry that may provide control of tacticity in the polymerization of propylene to isotactic polypropylene, when combined with appropriate activator(s).

[0116] In addition, specifics for the substituents on the ligands for production of the particular polymers discussed above (e.g., isotactic polypropylene) apply to the metal-ligand complexes. In addition, Lewis base adducts of the metal-ligand complexes in the above formulas are also suitable, for example, ethers, amines, thioethers, phosphines and the like are suitable as Lewis bases. The metal-ligand complexes can be formed by techniques known to those of skill in the art, such as combinations of metal precursors and ligands under conditions to afford complexation. For example, the complexes of this invention can be prepared according to the general scheme shown below:

[0117] As shown in Scheme 16, a ligand according to formula (IV) is combined with the metal precursor under conditions to cause the removal of at least 2 leaving group ligands L, which are shown in the scheme as combining with a hydrogen (H). Other schemes where the leaving group ligand combines with other moieties (e.g., Li) employing other known routes for complexation may be used, including for example, reactions where the ligand L reacts with other moieties (e.g., where the alkali metal salt of the ligand is used and the complexation reaction proceeds by salt climation).

[0118] Specific metal-ligand complexes with approximate C2 symmetry within the scope of the invention include:

[0119] The x-ray crystal structure of molecule C5 is shown in FIGS. 1a and 1b.

[0120] The ligands, complexes or catalysts may be supported on organic or inorganic supports. Suitable supports include silicas, aluminas, clays, zeolites, magnesium chloride, polystyrenes, substituted polystyrenes and the like. Polymeric supports may be cross-linked or not. Similarly, the ligands, complexes or catalysts may be supported on similar supports known to those of skill in the art. See for example, Hlatky, Chem. Rev. 2000, 100, 1347-1376 and Fink et al., Chem. Rev. 2000, 100, 1377-1390, both of which are incorporated herein by reference. In addition, the catalysts of this invention may be combined with other catalysts in a single reactor and/or employed in a series of reactors (parallel or serial) in order to form blends of polymer products.

[0121] The metal-ligand complexes and compositions are active catalysts typically in combination with a suitable activator, combination of activators, activating technique or activating package, although some of the ligand-metal complexes may be active without an activator or activating technique. Broadly, the activator(s) may comprise alumoxanes, Lewis acids, Bronsted acids, compatible non-interfering activators and combinations of the foregoing. These types of activators have been taught for use with different compositions or metal complexes in the following references, which are hereby incorporated by reference in their entirety: U.S. Pat. Nos. 5,599,761, 5,616,664, 5,453,410, 5,153,157, 5,064,802, EP-A-277,004 and Marks et al., Chem. Rev. 2000, 100, 1391-1434. In particular, ionic or ion forming activators are preferred.

[0122] Suitable ion forming compounds useful as an activator in one embodiment of the present invention comprise a cation that is a Bronsted acid capable of donating a proton, and an inert, compatible, non-interfering, anion, A−. Preferred anions are those containing a single coordination complex comprising a charge-bearing metal or metalloid core. Mechanistically, said anion should be sufficiently labile to be displaced by olefinic, diolefinic and unsaturated compounds or other neutral Lewis bases such as ethers or nitriles. Suitable metals include, but are not limited to, aluminum, gold and platinum. Suitable metalloids include, but are not limited to, boron, phosphorus, and silicon. Compounds containing anions that comprise coordination complexes containing a single metal or metalloid atom are, of course, well known and many, particularly such compounds containing a single boron atom in the anion portion are available commercially.

[0123] Specifically such activators may be represented by the following general formula:

(L*—H)d+(Ad−)

[0124] wherein L* is a neutral Lewis base; (L*—H)+ is a Bronsted acid; Ad− is a non-interfering, compatible anion having a charge of d−, and d is an integer from 1 to 3. More specifically Ad− corresponds to the formula: (M′3+Qh)d− wherein h is an integer from 4 to 6; h−3=d; M′ is an element selected from Group 13 of the Periodic Table of the Elements; and Q is independently selected from the group consisting of hydride, dialkylamido, halide, alkoxide, aryloxide, hydrocarbyl, and substituted-hydrocarbyl radicals (including halide substituted hydrocarbyl, such as perhalogenated hydrocarbyl radicals), said Q having up to 20 carbons. In a more specified embodiment, d is one, i.e., the counter ion has a single negative charge and corresponds to the formula A−.

[0125] Activators comprising boron or aluminum which are particularly useful in the preparation of catalysts of this invention may be represented by the following general formula:

(L*—H)+(JQ4)−

[0126] wherein: L* is as previously defined; J is boron or aluminum; and Q is a fluorinated C1-20 hydrocarbyl group. Most specifically, Q is independently selected from the group selected from the group consisting of fluorinated aryl group, especially, a pentafluorophenyl group (i.e., a C6F5 group) or a 3,5-bis(CF3)2C6H3 group. Illustrative, but not limiting, examples of boron compounds which may be used as an activating cocatalyst in the preparation of the improved catalysts of this invention are tri-substituted ammonium salts such as: trimethylammonium tetraphenylborate, triethylammonium tetraphenylborate, tripropylammonium tetraphenylborate, tri(n-butyl)ammonium tetraphenylborate, tri(t-butyl)ammonium tetraphenylborate, N,N-dimethylanilinium tetraphenylborate, N,N-diethylanilinium tetraphenylborate, N,N-dimethylanilinium tetra-(3,5-bis(trifluoromethyl)phenyl)borate, N,N-dimethyl-(2,4,6-trimethylanilinium) tetraphenylborate, trimethylammonium tetrakis(pentafluorophenyl) borate, triethylammonium tetrakis(pentafluorophenyl) borate, tripropylammonium tetrakis(pentafluorophenyl) borate, tri(n-butyl)ammonium tetrakis(pentafluorophenyl) borate, tri(secbutyl)ammonium tetrakis(pentafluorophenyl) borate, N,N-dimethylanilinium tetrakis(pentafluorophenyl) borate, N,N-diethylanilinium tetrakis(pentafluorophenyl) borate, N,N-dimethyl-(2,4,6-trimethylanilinium) tetrakis(pentafluorophenyl) borate, trimethylammonium tetrakis-(2,3,4,6-tetrafluorophenylborate and N,N-dimethylanilinium tetrakis-(2,3,4,6-tetrafluorophenyl) borate; dialkyl ammonium salts such as: di-(i-propyl)ammonium tetrakis(pentafluorophenyl) borate, and dicyclohexylammonium tetrakis(pentafluorophenyl) borate; and tri-substituted phosphonium salts such as: triphenylphospnonium tetrakis(pentafluorophenyl) borate, tri(o-tolyl)phosphonium tetrakis(pentafluorophenyl) borate, and tri(2,6-dimethylphenyl)phosphonium tetrakis(pentafluorophenyl) borate; N,N-dimethylanilinium tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; HNMe(C18H37)+B(C6F5)4−; HNPh(C18H37)+B(C6F5)4− and ((4-nBu-Ph)NH(n-hexyl)2)+B(C6F5)4−. Specific (L*—H)+ cations are N,N-dimethylanilinium and HNMe(C18H37)+. Specified anions are tetrakis(3,5-bis(trifluoromethyl)phenyl)borate and tetrakis(pentafluorophenyl)borate. In some embodiments, the specific activator is PhNMe2H+B(C6F5)4−.

[0127] Other suitable ion forming activators comprise a salt of a cationic oxidizing agent and a non-interfering, compatible anion represented by the formula:

(Oxe+)d(Ad−)e

[0128] wherein: Oxe+ is a cationic oxidizing agent having a charge of e+; e is an integer from 1 to 3; and Ad−, and d are as previously defined. Examples of cationic oxidizing agents include: ferrocenium, hydrocarbyl-substituted ferrocenium, Ag+, or Pb+2. Specific embodiments of Ad− are those anions previously defined with respect to the Bronsted acid containing activating cocatalysts, especially tetrakis(pentafluorophenyl)borate.

[0129] Another suitable ion forming, activating cocatalyst comprises a compound that is a salt of a carbenium ion or silyl cation and a non-interfering, compatible anion represented by the formula:

{circle over (c)}+A−

[0130] wherein: {circle over (c)}+ is a C1-100 carbenium ion or silyl cation; and A− is as previously defined. A preferred carbenium ion is the trityl cation, i.e. triphenylcarbenium. The silyl cation may be characterized by the formula Z4Z5Z6Si+ cation, where each of Z4, Z5, and Z6 is independently selected from the group consisting of hydride, halide, and optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, alkoxyl, aryloxyl, silyl, boryl, phosphino, amino, thioxy, alkylthio, arylthio, and combinations thereof. In some embodiments, a specified activator is Ph3C+B(C6F5)4−.

[0131] Other suitable activating cocatalysts comprise a compound that is a salt, which is represented by the formula (A*+a)b(Z*J*j)−cd wherein A* is a cation of charge +a; Z* is an anion group of from 1 to 50, specifically 1 to 30 atoms, not counting hydrogen atoms, further containing two or more Lewis base sites; J* independently each occurrence is a Lewis acid coordinated to at least one Lewis base site of Z*, and optionally two or more such J* groups may be joined together in a moiety having multiple Lewis acidic functionality; j is a number form 2 to 12; and a, b, c, and d are integers from 1 to 3, with the proviso that a×b is equal to c×d. See, WO 99/42467, which is incorporated herein by reference. In other embodiments, the anion portion of these activating cocatalysts may be characterized by the formula ((C6F5)3M″″—LN—M″″(C6F5)3) where M″″ is boron or aluminum and LN is a linking group, which is specifically selected from the group consisting of cyanide, azide, dicyanamide and imidazolide. The cation portion is specifically a quaternary amine. See, e.g., LaPointe, et al., J. Am. Chem. Soc. 2000, 122, 9560-9561, which is incorporated herein by reference.

[0132] In addition, suitable activators include Lewis acids, such as those selected from the group consisting of tris(aryl)boranes, tris(substituted aryl)boranes, tris(aryl)alanes, tris(substituted aryl)alanes, including activators such as tris(pentafluorophenyl)borane. Other useful ion forming Lewis acids include those having two or more Lewis acidic sites, such as those described in WO 99/06413 or Piers, et al. “New Bifunctional Perfluoroaryl Boranes: Synthesis and Reactivity of the ortho-Phenylene-Bridged Diboranes 1,2-(B(C6F5)2)2C6X4(X═H, F)”, J. Am. Chem. Soc., 1999, 121, 3244-3245, both of which are incorporated herein by reference. Other useful Lewis acids will be evident to those of skill in the art. In general, the group of Lewis acid activators is within the group of ion forming activators (although exceptions to this general rule can be found) and the group tends to exclude the group 13 reagents listed below. Combinations of ion forming activators may be used.

[0133] Other general activators or compounds useful in a polymerization reaction may be used. These compounds may be activators in some contexts, but may also serve other functions in the polymerization system, such as alkylating a metal center or scavenging impurities. These compounds are within the general definition of “activator,” but are not considered herein to be ion-forming activators. These compounds include a group 13 reagent that may be characterized by the formula G13R503−pDp where G13 is selected from the group consisting of B, Al, Ga, In and combinations thereof, p is 0, 1 or 2, each R50 is independently selected from the group consisting of hydride, halide, and optionally substituted alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, and combinations thereof, and each D is independently selected from the group consisting of halide, hydride, alkoxy, aryloxy, amino, thioxy, alkylthio, arylthio, phosphino and combinations thereof. In other embodiments, the group 13 activator is an oligomeric or polymeric alumoxane compound, such as methylalumoxane and the known modifications thereof. In other embodiments, a divalent metal reagent may be used that is defined by the general formula M′R502−p′Dp′ and p′ is 0 or 1 in this embodiment and R50 and D are as defined above. M′ is the metal and is selected from the group consisting of Mg, Ca, Sr, Ba, Zn, Cd and combinations thereof. In still other embodiments, an alkali metal reagent may be used that is defined by the general formula M″R50 and in this embodiment R50 is as defined above. M″ is the alkali metal and is selected from the group consisting of Li, Na, K, Rb, Cs and combinations thereof. Additionally, hydrogen and/or silanes may be used in the catalytic composition or added to the polymerization system. Silanes may be characterized by the formula SiR504−qDq where R50 is defined as above, q is 1, 2, 3 or 4 and D is as defined above, with the proviso that there is at least one D that is a hydride.

[0134] The molar ratio of metal:activator (whether a composition or complex is employed as a catalyst) employed specifically ranges from 1:10,000 to 100:1, more specifically from 1:5000 to 10:1, most specifically from 1:10 to 1:1. In one embodiment of the invention mixtures of the above compounds are used, particularly a combination of a group 13 reagent and an ion-forming activator. The molar ratio of group 13 reagent to ion-forming activator is specifically from 1:10,000 to 1000:1, more specifically from 1:5000 to 100:1, most specifically from 1:100 to 100:1. In another embodiment, the ion forming activators are combined with a group 13 reagent. Another embodiment is a combination of the above compounds having about 1 equivalent of N,N-dimethylanilinium tetrakis(pentafluorophenyl) borate, and 5-30 equivalents of a Group 13 reagent.

[0135] In other applications, the ligand will be mixed with a suitable metal precursor compound prior to or simultaneous with allowing the mixture to be contacted to the reactants. When the ligand is mixed with the metal precursor compound, a metal-ligand complex may be formed, which may be a catalyst.

[0136] The compositions, complexes and/or catalysts of this invention are particularly effective at polymerizing α-olefins (such as propylene, 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene, and styrene), copolymerizing ethylene with α-olefins (such as propylene, 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene, and styrene), and copolymerizing ethylene with 1,1-disubstituted olefins (such as isobutylene). These compositions might also polymerize monomers that have polar functionalities in homopolymerizations or copolymerizations and/or homopolymerize 1,1- and 1,2-disubstituted olefins. Also, diolefins in combination with ethylene and/or α-olefins or 1,1- and 1,2-disubstituted olefins may be copolymerized.

[0137] In general monomers useful herein may be olefinically or unsaturated monomers having from 2 to 20 carbon atoms either alone or in combination. Generally, monomers may include olefins, diolefins and unsaturated monomers including ethylene and C3 to C20 α-olefins such as propylene, 1-butene, 1-hexene, 1-octene, 4-methyl-1-pentene, 1-norbornene, styrene and mixtures thereof, additionally, 1,1-disubstituted olefins, such as isobutylene, 2-methyl-1-butene, 2-methyl-1-pentene, 2-ethyl-1-pentene, 2-methyl-1-hexene, 3-trimethylsilyl-2-methyl-1-propene, α-methyl-styrene, either alone or with other monomers such as ethylene or C3 to C20 α-olefins and/or diolefins; additionally 1,2-substituted olefins, such as 2-butene. The α-olefins listed above may be polymerized in a stereospecific manner e.g. to generate isotactic or syndiotactic or hemiisotactic polypropylene. Additionally the α-olefins may be polymerized to produce a polymer with differing tacticity sequences within the polymer chain, such as polypropylene containing atactic and isotactic sequences within the same polymer chain. These definitions are intended to include cyclic olefins. Diolefins generally comprise 1,3-dienes such as (butadiene), substituted 1,3-dienes (such as isoprene) and other substituted 1,3-dienes, with the term substituted referring to the same types of substituents referred to above in the definition section. Diolefins also comprises 1,5-dienes and other non-conjugated dienes. The styrene monomers may be unsubstituted or substituted at one or more positions on the aryl ring. The use of diolefins in this invention is typically in conjunction with another monomer that is not a diolefin. In some embodiments, acetylenically unsaturated monomers may be employed.

[0138] More specifically, it has been found that the catalysts of the present invention are particularly active for certain monomers, particularly α-olefins. Thus, the catalysts of the present invention may provide higher comonomer incorporation for copolymers of ethylene and co-monomers having three or more carbon atoms than is currently known from other catalysts. It has been found that particular catalysts of the present invention co-polymerize ethylene and styrene (or substituted styrenes), forming ethylene-styrene copolymers. Polymers that can be prepared according to the present invention include ethylene copolymers with at least one C3-C20 α-olefin, particularly propylene, 1-butene, 1-hexene, 4-methyl-1-pentene and 1-octene. The copolymers of ethylene with at least one C3-C20 α-olefin comprise from about 0.1 mol. % α-olefin to about 50 mol. % α-olefin, more specifically from about 0.2 mol. % α-olefin to about 50 mol. % α-olefin and still more specifically from about 2 mol. % α-olefin to about 30 mol. % higher olefin. For certain embodiments of this invention, copolymers include those of ethylene and a comonomer selected from the group consisting of propylene, 1-butene, 1-hexene, and 1-octene comprise from about 0.2 to about 30 mol. % comonomer, more specifically from about 1 to about 20 mol. % comonomer, even more specifically from about 2 to about 15 mol. % comonomer and most specifically from about 5 to about 12 mol. % comonomer.

[0139] Novel polymers, copolymers or interpolymers may be formed having unique physical and/or melt flow properties. Such novel polymers can be employed alone or with other polymers in a blend to form products that may be molded, cast, extruded or spun. End uses for the polymers made with the catalysts of this invention include films for packaging, trash bags, bottles, containers, foams, coatings, insulating devices and household items. Also, such functionalized polymers are useful as solid supports for organometallic or chemical synthesis processes.

[0140] The α-olefins listed above may be polymerized in a stereoselective manner e.g. to generate isotactic or syndiotactic or hemiisotactic poly-α-olefins. For example, 1-butene may be polymerized into isotactic poly-1-butene. Additionally the α-olefins may be polymerized to produce a polymer with differing tacticity sequences within the polymer chain, such as polypropylene containing atactic and isotactic sequences within the same polymer chain. The stereoregularity may be interrupted by stereoerrors, in particular isolated stereoerrors, which is an indication of enantiomorphic side control. Also regioerrors might be present in the isotactic polypropylene polymer as it is described in the literature (see, e.g., Resconi et al., “Selectivity in Propene Polymerization with Metallocene Catalysts,” Chem. Rev. 2000, 100, 1253-1345).

[0141] More specifically, it has been found that particular catalysts of the present invention polymerize propylene to isotactic or crystalline polypropylene, forming polymers with novel properties. The combination of isotactic polypropylene properties that are obtained at higher polymerization temperatures is surprising. In particular, isotactic polypropylene can be produced having a narrow polydispersity (e.g., less than about 3.0 and more specifically less than 2.5) combined with a high molecular weight (e.g., greater than about 50,000, more specifically greater than about 100,000 and even more specifically greater than about 150,000) in a solution polymerization process at a temperature of greater than about 100° C., more specifically greater than 110° C. and even more specifically greater than 130° C. In addition the isotactic polypropylene produced by certain embodiments of this invention can be prepared with few or no detectible using 13C NMR regio-errors (also known as regio-irrgularities). This is shown in FIG. 2 where the regio-errors are not detectible in certain isotactic polypropylene polymers prepared as discussed in the examples, using 13C NMR methods as described in Rescnoi et al. cited above. It is intended that the 13C NMR used herein are typical for polymer characterization.

[0142] The isotactic polypropylene polymers formed from these catalysts in a solution polymerization process can be produced at a higher temperature than has been described before, such as at a temperature of greater than about 100° C., more specifically greater than 110° C. and even more specifically greather than 130° C. The polymerization conditions are described herein, producing isotactic polypropylene with a crystallinity index of between about 0.35 and about 0.95, more specifically between about 0.65 and 0.95 and in some embodiments specifically above about 0.8, under the polymerization conditions employed. The crystallinity index is determined using FTIR as is known to those of skill in the art and calibrated based on a relative scale. In one embodiment, the crystallinity index value can be determined using commercially available FTIR equipment (such as a Bruker Equinox 55 with an IR Scope II in reflection mode using Pike MappIR software). The crystallinity index is obtained from the ratio of band heights at 995 cm−1 and 972 cm−1. Atactic polypropylene has a ratio of band heights or crystallinity index of 0.2. Greater than 98% isotactic polypropylene has a crystallinity index ratio of greater than 0.95. Generally, the amount of error in crystallinity index measurements is ±0.05. Polymer blends of various compositions show a linear relationship between % isotacticity and crystallinity index. See, for example, J. P. Luongo, J. Appl. Polym. Sci., 3 (1960) 302-309 and T. Sundell, H. Fagerholm, H. Crozier, Polymer 37 (1996) 3227-3231, each of which is incorporated herein by reference.

[0143] As those of skill in the art will recognize, isotacticity can also be represented by percent pentads (% mmmm) as determined by 13C NMR spectroscopy. Proton decoupled 13C NMR spectroscopy can be performed using commercially available equipment (such as a Bruker 300 MHz at 100° C. probe temperature) to determine the degree of tacticity as % mmmm pentads (for assignment of 13C signals see the review Brintzinger H. H. et al., Angew. Chem. Int. Ed. Eng. 1995, 34, 1143, which is incorporated herein by reference; and Resconi, Chem. Rev. 2000, 100, 1253-1345 and Gibson, et al., Chem Rev. 2003, 103, 283-315). For example, a 15-30 mg polymer sample is dissolved in a 1:1 mixture of C2D2Cl4 and C2Cl4 by heating the sample to ca. 100° C. The % mmmm is determined by the ratio of peak integral from 23.5 to 21.5 ppm and peak integral 23.5 to 19 ppm (in the absence of significant chain end regio-irregularity signals in this region). Proton decoupled 13C NMR spectroscopy can be also performed to determine the frequency of and nature of stereoerrors and regioerrors.

[0144] In addition, the melting point of the crystalline polypropylene is generally in the range of from about 115° C. to about 165° C., more specifically between about 120° C. and 155° C., and in some embodiments specifically above about 135° C. Melting points are determined by differential scanning calorimetry, as is known in the art (see also the example section, herein).

[0145] Novel polymers, copolymers or interpolymers may be formed having unique physical and/or melt flow properties. Polymers that can be prepared according to the present invention include propylene copolymers with at least one C4-C20 α-olefin, particularly 1-butene, 1-hexene, 4-methyl-1-pentene and 1-octene. The copolymers of propylene with at least one C4-C20 α-olefin comprise from about 0.1 wt. % higher olefin to about 60 wt. % higher olefin, more specifically from about 0.2 wt. % higher olefin to about 50 wt. % higher olefin and still more specifically from about 2 wt. % higher olefin to about 30 wt. % higher olefin. For certain embodiments of this invention, crystalline copolymers include those of propylene and a comonomer selected from the group consisting of ethylene, 1-butene, 1-hexene, and 1-octene comprise from about 0.2 to about 30 wt. % comonomer, more specifically from about 1 to about 20 wt. % comonomer, even more specifically from about 2 to about 15 wt. % comonomer and most specifically from about 5 to about 12 wt. % comonomer.

[0146] The novel polymers (such as isotactic polypropylene) disclosed herein can be employed alone or with other natural or synthetic polymers in a blend. Such other natural or synthetic polymers can be polyethylene (including linear low density polyethylene, low density polyethylene, high density polyethylene, etc.), atactic polypropylene, nylon, EPDM, ethylene-propylene elastomer copolymers, polystyrene (including syndiotactic polystryene), ethylene-styrene copolymers and terpolymers of ethylene-styrene and other C3-C20 olefins (such as propylene).

[0147] Melt flow rate (MRF) for polypropylene and copolymer of propylene and one or more C4-C20 α-olefins is measured according to ASTM D-1238, condition L (2.16 kg, 230° C.). In some embodiments of this invention, the MFR is in the range of 0.005-1,000, more specifically 0.01-500 and even more specifically 0.1-100. Flex modulus for polypropylene and copolymer of propylene and one or more C4-C20 α-olefins is measured according to ASTM D-790. In some embodiments of this invention, the flex modulus ranges from 20,000-400,000 psi, more specifically from 20,000-300,000 psi and even more specifically from 100,000-200,000 psi. Notch izod impact for polypropylene and copolymer of propylene and one or more C4-C20 α-olefins is measured according to ASTM D-256A. In some embodiments of this invention, the notch izod impact ranges from 0.1 to no break in ft-lbs/in.

[0148] The novel polypropylene and copolymer of propylene and one or more C4-C20 α-olefins disclosed in the present invention are useful for a wide variety of applications, including films (such as blown and cast film, clarity film and multi-layer films), thermoforming (such as cups, plates, trays and containers), injection moulding, blow-moulding, foams (such as structural foams), pipe (such as potable water pipe and high pressure pipe), automotive parts, and other applications that will be evident to those of skill in the art.

[0149] Melt strength (measured in cN) and melt drawability (measured in mm/s) tests are conducted by pulling (“taking-up”) strands of the molten polymers or blends at constant acceleration until breakage occurs. An experimental set-up comprises a capillary rheometer and a Rheotens apparatus as a take-up device. The molten strands are drawn uniaxially to a set of accelerating nips located 100 mm below the die. The force required to uniaxially extend the strands is recorded as a function of the take-up velocity or the nip rolls. In the case of polymer melts exhibiting draw resonance (indicated by the onset of a periodic oscillation of increasing amplitude in the measured force profile), the maximum force and wheel velocity before the onset of draw resonance are taken as the melt strength and melt drawability, respectively. In the absence of draw resonance, the maximum force attained during testing is defined as the melt strength and the velocity at which breakage occurs is defined as the melt drawability. These tests are typically run under the following conditions:

1Mass flow rate 1.35 grams/minTemperature 190° C.Equilibration time at 190° C. 10 minutesDie20:1 (with entrance angle ofapproximately 45 degrees)Capillary length 41.9 mmCapillary diameter 2.1 mmPiston diameter 9.54 mmPiston velocity0.423 mm/sShear rate 33.0 s−1Draw-down distance (die exit to take-up 100 mmsheels)Cooling conditionsAmbient airAcceleration 2.4 mm/s2

[0150] For some aspects of the present invention the novel polymers are useful to produce foams having improved properties. For foams and other applications requiring melt strength, the MFR is typically in the range of 0.1-10, more specifically in the range of 0.3-3 and most specifically in the range of 0.5-2. The melt strength is typically greater than 5 cN, more specifically greater than 9 cN and most specifically greater than 12 cN. The drawability is typically greater than 15 mm/sec, more specifically greater than 25 mm/sec and most specifically greater than 35 mm/sec.

[0151] In some aspects of the present invention, the novel polymers disclosed herein are useful for a wide variety of applications where certain optical properties are beneficial. Gloss is measured according to ASTM D-1746. Haze is measured according to ASTM D-1003 and clarity is measured according to ASTM D-2457. The novel polymers disclosed herein in some aspects are films having haze of less than 10%. In addition films having clarity of greater than 91% may be beneficially obtained.

[0152] Polymerization is carried out under polymerization conditions, including temperatures of from −100° C. to 300° C. and pressures from atmospheric to 3000 atmospheres. Suspension, solution, slurry, gas phase or high-pressure polymerization processes may be employed with the catalysts and compounds of this invention. Such processes can be run in a batch, semi-batch or continuous mode. Examples of such processes are well known in the art. A support for the catalyst may be employed, which may be inorganic (such as alumina, magnesium chloride or silica) or organic (such as a polymer or cross-linked polymer). Methods for the preparation of supported catalysts are known in the art. Slurry, suspension, gas phase and high-pressure processes as known to those skilled in the art may also be used with supported catalysts of the invention.

[0153] Other additives that are useful in a polymerization reaction may be employed, such as scavengers, promoters, modifiers and/or chain transfer agents, such as hydrogen, aluminum alkyls and/or silanes.

[0154] As discussed herein, catalytic performance can be determined a number of different ways, as those of skill in the art will appreciate. Catalytic performance can be determined by the yield of polymer obtained per mole of metal complex, which in some contexts may be considered to be activity. The examples provide data for these comparisons.

[0155] Another measure of catalyst polymerization performance is co-monomer incorporation. As is well known in the art, many ethylene copolymers are prepared using ethylene and at least one other monomer. These copolymers or higher order polymers in some applications require higher amounts of additional co-monomer(s) than have been practical with known catalysts. Since ethylene tends to be the most reactive monomer, obtaining higher co-monomer incorporations is a benefit that is examined for polymerization catalysts. Two useful co-monomers are 1-octene and styrene. This invention offers the possibility of higher incorporation of co-monomers such as 1-octene and styrene.

[0156] As stated herein, a solution process is specified for certain benefits, with the solution process being run at a temperature above 90° C., more specifically at a temperature above 100° C., further more specifically at a temperature above 110° C. and even further more specifically at a temperature above 130° C. Suitable solvents for polymerization are non-coordinating, inert liquids. Examples include straight and branched-chain hydrocarbons such as isobutane, butane, pentane, isopentane, hexane, isohexane, heptane, octane, Isopar-E® and mixtures thereof; cyclic and alicyclic hydrocarbons such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane, and mixtures thereof; perhalogenated hydrocarbons such as perfluorinated C4-10 alkanes, chlorobenzene, and aromatic and alkyl substituted aromatic compounds such as benzene, toluene, mesitylene, and xylene. Suitable solvents also include liquid olefins which may act as monomers or comonomers including ethylene, propylene, 1-butene, butadiene, cyclopentene, 1-hexene, 1-pentene, 3-methyl-1-pentene, 4-methyl-1-pentene, 1,4-hexadiene, 1-octene, 1-decene, isobutylene, styrene, divinylbenzene, allylbenzene, and vinyltoluene (including all isomers alone or in admixture). Mixtures of the foregoing are also suitable.

[0157] In some embodiments, a solution process is specified for crystalline polypropylene production. The solution process to prepare isotactic polypropylene comprises adding a catalyst and propylene monomer to a reactor and subjecting the contents to polymerization conditions.

[0158] The ligands, metal-ligand complexes and compositions of this invention can be prepared and tested for catalytic activity in one or more of the above reactions in a combinatorial fashion. Combinatorial chemistry generally involves the parallel or rapid serial synthesis and/or screening or characterization of compounds and compositions of matter. U.S. Pat. Nos. 5,985,356, 6,030,917 and WO 98/03521, all of which are incorporated herein by reference, generally disclose combinatorial methods. In this regard, the ligands, metal-ligand complexes or compositions may be prepared and/or tested in rapid serial and/or parallel fashion, e.g., in an array format. When prepared in an array format, ligands, metal-ligand complexes or compositions may be take the form of an array comprising a plurality of compounds wherein each compound can be characterized by any of the above general formulas (i.e., I, II, III, etc.). An array of ligands may be synthesized using the procedures outlined previously. The array may also be of metal precursor compounds, the metal-ligand complexes or compositions characterized by the previously described formulae and/or description. Typically, each member of the array will have differences so that, for example, a ligand or activator or metal precursor or R group in a first region of the array may be different than the ligand or activator or metal precursor or R group in a second region of the array. Other variables may also differ from region to region in the array.

[0159] In such a combinatorial array, typically each of the plurality of compositions or complexes has a different composition or stoichiometry, and typically each composition or complex is at a selected region on a substrate such that each compound is isolated from the other compositions or complexes. This isolation can take many forms, typically depending on the substrate used. If a flat substrate is used, there may simply be sufficient space between regions so that there cannot be interdiffusion between compositions or complexes. As another example, the substrate can be a microtiter or similar plate having wells so that each composition or complex is in a region separated from other compounds in other regions by a physical barrier. The array may also comprise a parallel reactor or testing chamber.

[0160] The array typically comprises at least 8 compounds, complexes or compositions each having a different chemical formula, meaning that there must be at least one different atom or bond differentiating the members in the array or different ratios of the components referred to herein (with components referring to ligands, metal precursors, activators, group 13 reagents, solvents, monomers, supports, etc.). In other embodiments, there are at least 20 compounds, complexes or compositions on or in the substrate each having a different chemical formula. In still other embodiments, there are at least 40 or 90 or 124 compounds, complexes or compositions on or in the substrate each having a different chemical formula. Because of the manner of forming combinatorial arrays, it may be that each compound, complex or composition may not be worked-up, purified or isolated, and for example, may contain reaction by-products or impurities or unreacted starting materials.

[0161] The catalytic performance of the compounds, complexes or compositions of this invention can be tested in a combinatorial or high throughput fashion. Polymerizations can also be performed in a combinatorial fashion, see, e.g., U.S. Pat. Nos. 6,306,658, 6,508,984 and WO 01/98371, each of which is herein incorporated by reference.

EXAMPLES

[0162] General: All reactions were performed under a purified argon or nitrogen atmosphere in a Braun or Vacuum Atmospheres glove box. All solvents used were anhydrous, de-oxygenated and purified according to known techniques. All ligands and metal precursors were prepared according to procedures known to those of skill in the art, e.g., under inert atmosphere conditions, etc. Ethylene/styrene and ethylene/1-octene copolymerizations and propylene polymerizations were carried out in a parallel pressure reactor, which is fully described in U.S. Pat. Nos. 6,306,658, 6,455,316 and 6,489,168, and in U.S. application Ser. No. 09/177,170, filed Oct. 22, 1998, and WO 00/09255, each of which is incorporated herein by reference.

[0163] High temperature Size Exclusion Chromatography was performed using an automated “Rapid GPC” system as described in U.S. Pat. Nos. 6,491,816, 6,491,823, 6,475,391, 6,461,515, 6,436,292, 6,406,632, 6,175,409, 6,454,947, 6,260,407, and 6,294,388 each of which is incorporated herein by reference. In the current apparatus, a series of two 30 cm×7.5 mm linear columns, with one column containing PLgel 10 um, MixB and the other column containing PLgel 5 um, MixC (available from Polymer Labs). The GPC system was calibrated using narrow polystyrene standards. The system was operated at a eluent flow rate of 1.5 mL/min and an oven temperature of 160° C. o-dichlorobenzene was used as the eluent. The polymer samples were dissolved 1,2,4-trichlorobenzene at a concentration of about 1 mg/mL. Between 40 μL and 200 μL of a polymer solution were injected into the system. The concentration of the polymer in the eluent was monitored using an evaporative light scattering detector. All of the molecular weight results obtained are relative to linear polystyrene standards.

[0164] The ratio of 1-octene to ethylene incorporated in the ethylene-octene copolymer products was determined by Raman spectroscopy. All spectra were obtained using a Bruker Equinox 055 FRA 106/S FT-Raman Spectrometer (Raman back scattering) with a 4 min acquisition time, a laser power of 500 mW, and spectral resolution of 4 cm−1. Analysis was performed using OPUS NT software package by measuring the absorbance of the peaks at 2953, 2955, and 2957 cm−1 (for the asymmetric CH3 stretch) and the peak maximum between 2844 and 2854 cm−1 (for the symmetric CH2 stretch). The absorbance of the baseline at 3200 cm−1 was then subtracted from these values and the ratio of the peak heights was determined. Mol % 1-octene values determined from x=A2953/A2850 ratio where Mol %=1233.2×2−160.26x+8.2296. This method was calibrated using a set of ethylene/1-octene copolymers with a range of known wt. % 1-octene content.

[0165] Crystallinity in polypropylene was determined by FTIR spectroscopy. FTIR spectra of thin films deposited from solution onto gold coated Si wafers are acquired at 4 cm−1 resolution and with 16 scans in reflection-absorption mode on a Bruker Equinox 55 FTIR spectrometer equipped with a Pike MappIR accessory. The height ratio of two bands at 995 cm−1 (C—H bending and CH3 rocking mode from regular crystalline isotactic helices) and 972 cm−1 (coupled C—C stretching and CH3 rocking mode, independent of crystallinity) is determined as a measure of isotacticity (as known in the art, see, e.g., J. P. Luongo, J. Appl. Polym. Sci 3 (1960) 302-309, and T. Sundell, H. Fagerholm, H. Crozier, Polymer 37 (1996) 3227-3231, each of which is incorporated herein by reference). For blends of atactic and isotactic polypropylene (PP) with 0-70% isotactic PP, the IR ratio is proportional to the percentage of isotactic PP. For greater than 98% isotactic PP the ratio is greater than 0.95, for amorphous PP the ratio is 0.2.

[0166] The ratio of styrene to ethylene incorporated in the polymer products, represented as the mol % of styrene incorporated in the polymer (mol % styrene) was determined using FTIR spectroscopy. The IR spectra (16 scans at 4 cm−1 resolution) analyzed by Partial Least Squares (PLS) analysis with PLSplus/IQ V3.04 for GRAMS/32 (Galactic Industries) software, using the following training set for calibration.

[0167] Training Set

[0168] The analysis based on a training set consisting of 180 spectra of blends of ethylene-styrene copolymers with known styrene incorporation, and atactic homo-polystyrene. The 16 known copolymers had between 1 and 47 mol % incorporated styrene. The atactic homo-polystyrene content in the blends ranged from 0 to 90% of the total styrene content of the blend. Most blends are prepared from copolymers with up to 20 mol % incorporation. Multiple spectra per blend were included in the training set.

[0169] Preprocessing of the Spectra

[0170] Mean centering; linear baseline correction based on average absorbances at 2074 cm−1-2218 cm−1 and 3224 cm−1-3465 cm−1; thickness correction based on band area from 1483 cm−1 to 1504 cm−1 with baseline from 1389 cm−1-1413 cm−1 to 1518 cm−1-1527 cm−1.

[0171] Analysis

[0172] PLS-1 algorithm; spectral regions 499 cm−1 to 2033 cm−1 and 3577 cm−1 to 4495 cm−1. Prediction of number ratios of atactic homo-polystyrene to total styrene (∝ % atactic homo-polystyrene to total styrene) with 10 factors and ethylene to total styrene (∝ mol % total styrene) with 7 factors and calculation of mol % incorporated styrene from these 2 numbers.

[0173] FTIR method for determining mol % total styrene in product: FTIR was performed on a Bruker Equinox 55+IR Scope II in reflection mode using a Pike MappIR accessory with 16 scans. The ratio of total styrene to ethylene was obtained from the ratio of band heights at 4330 cm−1 and 1602 cm−1. This method was calibrated using a set of ethylene-styrene copolymers with a range of known styrene content. The total styrene content of the polymer products (mol % total styrene), includes both the styrene incorporated in the ethylene-styrene copolymer and any background homopolystyrene (PS) in the product sample. For the ethylene-styrene copolymerization conditions employed, the homopolystyrene background level is typically less than 3.5 wt % (1 mol %).

[0174] Differential Scanning Calorimetry (DSC) measurements were performed on a TA instrument DSC 2920 to determine the melting point of polymers. The sample was equilibrated at 200° and held for 4 minutes. The sample was cooled to −50° C. with a rate of 10° C./min and held at −50° C. for 4 minutes. Then, the sample was heated to 200° C. at a rate of 10° C./min and data were collected during that heating period.

[0175] List of Abbreviations used in this section include: Me=methyl, Et=ethyl, Bn or Bz=benzyl, Ac=CH3CO, EA=ethyl acetate, Ts=tosyl=para-toluenesulfonyl, THP=tetrahydropyran, dppf=1,1′-bis(diphenylphosphino)ferrocene, MOM=methoxymethyl=CH3OCH2—, DMF=dimethylformamide

[0176] The ligands in these examples are prepared according to the general schemes described above and shown below, where “building blocks” are first prepared and then coupled together.

[0177] Part A: Synthesis of Building Blocks

[0178] Part 1: Synthesis of Substituted 2-Bromophenols and 2-Bromophenylether Building Blocks:

Example 1

[0179] Scheme A1:

[0180] Building Blocks BB1 and BB2:

[0181] Step 1: CuI-Catalyzed Cross-Coupling:

[0182] A solution of the protected 2-bromophenol (4.6 mmol) and carbazole (5.5 mmol) in dioxane (8 mL) was degassed with argon. CuI (0.215 mmol, 5%), racemic trans-1,2-diaminocyclohexane (0.86 mmol, 20%), and K3PO4 (8 mmol) were added and the resulting mixture was stirred at 100° C. for 16 h. After filtration, the solvent was removed and crude product was purified by flash chromatography to give 4.04 mmol of the product (88% yield).

[0183] Step 2: Cleavage of the Methyl Ether:

[0184] To a solution of the carbazole methyl ether in dry CH2Cl2 were added two equivalents of BBr3 (1 M solution in CH2Cl2) and the resulting solution was stirred for 5 hours (TLC control). Water was added, the resulting mixture was extracted with ethyl acetate, and the organic layer was dried over Na2SO4. The crude product was purified by flash chromatography.

[0185] Step 3: Bromination:

[0186] To a solution of the carbazole phenol (4.3 mmol) and NEt3 (4.3 mmol) in CH2Cl2 (10 ml) was added dropwise a solution of NBS (N-bromosuccinimide, 4.8 mmol) in CH2Cl2 (30 mL). The resulting solution was stirred for 30 min and then quenched with 2N HCl (5 mL). Water (30 mL) was added, the mixture was extracted with CH2Cl2, and the organic layer was dried over Na2SO4. The crude product was purified by flash chromatography to give 1.8 mmol of the product (43% yield) (JZ-1009-31). 1H NMR (300 MHz, CDCl3): 8.15 (d, 2H), 7.11-7.52 (m, 8H), 5.35 (s, 1H), 2.34 (s, 3H). (GC-MS available)

[0187] Step 4: Protection of Phenol as Methyl Ether (BB1) or Benzyl Ether (BB2):

[0188] A mixture of a phenol building block (1 equiv.), MeI or BnBr (1.5 equiv.) and K2CO3 (2 equiv.) in acetone (ca. 0.5 mmol/ml) was stirred at 60° C. for 2-4 hours. After addition of CH2Cl2 and filtration, the solvent was removed in vacu and the crude product was dried in a vacuum oven.

[0189] Some additional 2-bromophenol building blocks synthesized in a manner similar to that described in Scheme A1(a):

[0190] Synthesis of 2-Bromophenol Building Block BB5:

[0191] Step 1: n-BuLi (22.5 mmol, from a 1.6 M solution in hexanes, 14 mL) was added slowly to a solution of the aryl bromide (21.44 mmol, 5 g) in THF (50 mL, anhydrous) at −78° C. under an atmosphere of argon. After stirring for 30 min at that temperature, triisopropyl borate (25.7 mmol, 6 mL) was added slowly and the temperature was allowed to come to room temperature (30 min). After stirring for another 30 min, the solvent was removed and the crude boronic acid was used without further purification.

[0192] Step 2: A mixture of the protected 2-bromophenol (methyl ether, 3.38 g, 16.8 mmol), the boronic acid (22.5 mmol), Na2CO3 (9 mL of a 2 M solution in water, 18 mmol) and dimethoxy ethane (100 mL) was degassed with argon. Pd(PPh3)3 (485 mg, 0.42 mmol, 2.5%) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. Ethyl acetate (30 mL) was added and the mixture was dried over Na2SO4. After filtration, the solvent was removed and the crude product was purified by flash chromatography (Ethylacetate/hexane=1/10) to give 1.7 g of the cross-coupling product (6 mmol, 28% yield). After cleavage of the methyl ether with BBr3 in CH2Cl2 and bromination with NBS as shown in Scheme A1(a), the crude product was purified to yield 1.4 g of the building block BB5 (4.13 mmol, 68%). (characterized by GC-MS, 1H NMR).

[0193] Some additional 2-bromophenol building blocks (BB6 to BB12) synthesized in a manner similar to that described above in connection with Scheme A1(b):

[0194] 2-bromophenol building blocks synthesized in a manner similar to that described above for Scheme A1(c) (only bromination and deprotection):

Example 2

[0195] Scheme A2: Synthesis of Substituted 2-Bromophenyl-Benzyl Ethers via 2,6-dibromo-4-methyl-phenyl Benzyl Ether

[0196] Synthesis of Building Block BB16:

[0197] n-BuLi (4 mmol, from a 1.6 M solution in hexanes, 2.5 mL) was added slowly to a solution of the aryl bromide (3.72 mmol, 1 g) in THF (10 mL, anhydrous) at −78° C. under an atmosphere of argon. After stirring for 10 min at that temperature, triisopropyl borate (4.3 mmol, 988 μL) was added slowly and the temperature was allowed to come to room temperature (30 min). After stirring for another 30 min, the solvent was removed and the crude aryl boronic acid was used without further purification. A mixture of the protected 2,6-dibromophenol (benzyl ether, 1.07 g, 3 mmol), the boronic acid (3.72 mmol), Na2CO3 (2.5 mL of a 2 M solution in water, 5 mmol) and dimethoxy ethane (15 mL) was degassed with argon. Pd(PPh3)3 (170 mg, 0.15 mmol, 5%) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. Ethyl acetate (30 mL) was added and the mixture was dried over Na2SO4. After filtration, the solvent was removed and the crude product was purified by flash chromatography (Ethylacetate/hexane=1/10) to give 1.143 g of the product BB16 (2.46 mmol, 82% yield).

[0198] Some additional building blocks synthesized in a manner similar to that described above in connection with Scheme A2(a):

[0199] Part 2: Synthesis of Boronic Ester Building Blocks

Example 3

[0200] Scheme A3:

[0201] Introduction of the THP (tetrahydropyran) protection group—A solution of 2-bromophenol (25 g, 145 mmol), dihydropyran (22.3 g, 264 mmol) and pyridinium p-toluenesulfonate (“PPTs”, 3.3 g, 13 mmol) in methylene chloride (100 mL) was stirred for 16 h at room temperature. The resulting solution was washed with aq. NH4Cl, H2O and brine, and dried over Na2SO4. After removal of the solvent, the THP-protected 2-bromophenol was isolated as a yellow oil (35 g, 137 mmol, 95%).

[0202] Formation of the boronic ester—n-BuLi (1.1 mol, from a 1.6 M solution in hexanes) was added slowly to a solution of the THP-protected 2-bromophenol (1 mmol) in THF (5 mL, anhydrous) at −78° C. under an atmosphere of argon. After stirring for 10 min at that temperature, triisopropyl borate was added slowly and the temperature was allowed to come to room temperature (30 min). After stirring for another 30 min, the solvent was removed and the crude THP-protected boronic ester (BB20) was used without fuirther purification.

[0203] Some additional building blocks synthesized in a manner similar to that described above in connection with Scheme A3:

Example 4

[0204] Scheme A4:

[0205] A solution of bromobenzenethiol (25 g, 132 mmol), dihydropyran (22.3 g, 264 mmol) and pyridinium p-toluenesulfonate (“PPTs”, 3.3 g, 13 mmol) in methylene chloride (100 mL) was stirred for 16 h at room temperature. The resulting solution was washed with aq. NH4Cl, H2O and brine, and dried over Na2SO4. After removal of the solvent, the THP-protected 2-bromothiophenol was isolated as a yellow oil (34 g, 125 mmol, 95%). The corresponding THP-protected boronic ester (BB21) was prepared according to standard methods described above.

[0206] Part 3: Synthesis of (O,O)- and (O,S)-Bridged Building Blocks

Example 5

[0207] (O,O)-Bridged Building Block BB22:

[0208] A mixture of bromophenol (40 mmol, 4.64 mL), 1,3-dibromopropane (20 mmol, 2.03 mL) and Cs2CO3 (50 mmol, 16.3 g) in acetone (100 mL) was stirred at 60° C. for 16 hours. After addition of CH2Cl2 and filtration, the solvent was removed in vacu and the crude product was dried in a vacuum oven to give 5.77 g of BB22 (75%). (characterized by GC-MS, 1H NMR)

Example 6

[0209] (O,S)-Bridged Building Block BB23:

[0210] A mixture of bromophenol (4.62 mmol, 800 mg), 1,4-dibromobutane (20 mmol, 4.32 g) and K2CO3 (10 mmol, 1.38 g) in acetone (10 mL) was stirred at 60° C. for 1 hour. After addition of CH2Cl2 and filtration, the solvent was removed and the crude product was purified by flash chromatography (Ethylacetate/hexane=1/10) to give 1.278 g of the product (4.15 mmol, 90% yield). Bromothiophenol (4.15 mmol, 784 mg), K2CO3 (10 mmol, 1.38 g) and acetone (10 mL) were added and the resulting mixture was stirred at 60° C. for 2 hours. After addition of CH2Cl2 and filtration, the solvent was removed to give 1.693 g of the product BB23 (4.07 mmol, 88% yield). (characterized by GC-MS, 1H NMR)

Example 7

[0211] Synthesis of (O,O)- and (O,S)-Bridged Bis Aryl Boronic Esters:

[0212] Building Block BB24:

[0213] A mixture of the (O,O)-bridged bis(arylbromide) BB22 (397 mg, 1.03 mmol), the boronic ester (574 mg, 2.26 mmol), KOAc (607 mg, 6.16 mmol) and toluene (15 mL) was degassed with argon. PdCl2(dppf) (50 mg, 0.06 mmol) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. After filtration, the solvent was removed and the crude product was purified by flash chromatography (CH2Cl2/hexane=10/1, add 1% of NEt3) to give 240 mg of the product (O,O)-bridged bis(aryl boronic ester) BB24 (0.5 mmol, 50% yield).

[0214] Building Block BB25:

[0215] A mixture of the (O,S)-bridged bis(arylbromide) BB23 (416 mg, 1 mmol), the boronic ester (559 mg, 2.2 mmol), KOAc (588 mg, 6 mmol) and toluene (15 mL) was degassed with argon. PdCl2(dppf) (50 mg, 0.06 mmol) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. After filtration, the solvent was removed and the crude product was purified by flash chromatography (CH2Cl2/hexane=10/1, add 1% of NEt3) to give 110 mg of the product (O,S)-bridged bis(aryl boronic ester) BB25 (0.5 mmol, 50% yield).

[0216] Part B: Synthesis of (O,O)-Bridged Bis(Biphenylphenol) Ligands:

[0217] Detailed Example of a Ligand Synthesized According to Scheme B1:

Example 8

[0218] Building Block BB26: Procedure B1 Step 1:

[0219] A mixture of the benzyl ether protected 2-bromophenol (BB14, 670 mg, 1.7 mmol), the in situ formed O-THP protected ary boronic acid (BB20, 750 mg, 2.5 mmol), Na2CO3 (1.5 mL of a 2 M solution in water, 3 mmol) and dimethoxy ethane (10 mL) was degassed with argon. Pd(PPh3)3 (230 mg, 0.2 mmol, 10%) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. Ethyl acetate (30 mL) was added and the mixture was dried over Na2SO4. After filtration, the solvent was removed and the THP ether was cleaved in the presence of HCl (0.2 mL), EA (1 mL), and MeOH (1 mL). The crude product was purified by flash chromatography (Ethylacetate/hexane=1/10) to give 638 mg of the product BB26 (1.56 mmol, 92% yield). 1H NMR (300 MHz, CDCl3): 7.64 (d br, J=7 Hz, 2H), 7.35-7.52 (m, 7H), 7.05-7.25 (m, 5H), 7.72 (d br, J=7 Hz, 2H), 4.27 (s, 2H), 1.40 (s, 9H).

Example 9

[0220] Ligand LL1: Procedure B1 Step 2:

[0221] A mixture of the phenol building block (BB26) (418 mg, 1.01 mmol), 1,4-dibromobutane (109 mg, 0.5 mmol), and K2CO3 (260 mgs, 2 mmol) in acetone (5 mL) was stirred at 60° C. for 16 hours. After filtration, the solvent was removed and the crude product was dissolved in ethyl acetate (2 mL) and EtOH (2 mL). Pd (100 mg, 10% on activated carbon) was added and the suspension was stirred under an atmosphere of hydrogen for 16 h at room temperature and at 50° C. for 3 hours. After filtration and removal of the solvent, the crude product was purified by flash chromatography (Ethylacetate/hexane=1/10) to yield 205 mg of the final product LL1 as a white solid (0.297 mmol, 59%). 1H NMR (300 MHz, CDCl3): 7.52 (d br, J=7 Hz, 4H), 7.36 (t br, J=7 Hz, 4H), 7.26-7.34 (m, 8H), 7.18 (d, J=2.5 Hz, 2H), 7.09 (t, J=7.5 Hz, 2H), 6.89 (d, J=8 Hz, 2H), 6.00 (s, 2H), 3.94 (br, 4H), 1.78 (br, 4H), 1.32 (s, 18H).

[0222] Some additional ligands synthesized in a method similar to that just described according to Scheme B1 chosen to exemplify some variations in the synthetic method:

Example 10

[0223] Building Block BB27:

[0224] According to Scheme B1 and General Procedure B1 Step 1, the in situ generated O-THP boronic acid BB20 (0.7 mmol), the protected 2-bromophenol building block BB16 (0.5 mmol, 232 mg), Na2CO3 (0.5 mL of a 2 M solution in water, 1 mmol) and dimethoxy ethane (7 mL) were reacted in the presence of Pd(PPh3)3 (80 mg, 0.07 mmol) at 85° C. for 16 h. After cleavage of the THP ether and purification, 128 mg of the product BB27 was obtained (0.268 mmol, 54% yield). 1H NMR (300 MHz, CDCl3): 7.52 (t, J=2 Hz, 1H), 7.35-7.42 (m, 5H), 7.22-7.30 (m, 2H), 7.05-7.20 (5H), 6.65 (dbr, J=7 Hz, 2H), 4.29 (s, 2H), 2.47 (s, 3H), 1.34 (s, 18H).

Example 11

[0225] Ligand LL2:

[0226] According to Scheme B1 and General Procedure B1 Step 2, a mixture of the phenol building block BB27 (128 mg, 0.268 mmol), propane-1,3-diol-di-p-tosylate (51 mg, 0.134 mmol), and Cs2CO3 (163 mgs, 0.5 mmol) in acetone (2 mL) was stirred at 60° C. for 16 hours. After stirring the benzyl ether under an atmosphere of H2 (500 psi) in the presence of Pd/C (50 mg, 5%, Aldrich) in ethyl acetate (1 mL), EtOH (1 mL) and AcOH (1 drop) at 50° C. for 2 h, the product was purified by flash chromatography to give 54 mg of the product LL2 (0.066 mmol, 50% yield). 1H NMR (300 MHz, CDCl3): 7.48 (d, J=1 Hz, 2H), 7.32-7.40 (m, 6H), 6.98-7.20 (m, 8H), 6.76 (d, J=8 Hz, 2H), 5.70 (s, 2H), 4.06 (t, J=6 Hz, 4H), 2.33 (s, 6H), 2.05 (tt, J=6 Hz, 2H), 1.31 (s, 36H).

Example 12

[0227] Ligand LL3:

[0228] According to Scheme B1 and General Procedure B1 Step 2, a mixture of the phenol building block BB27 (100 mg, 0.209 mmol), 1,4-dibromobutane (23 mg, 0.105 mmol), and Cs2CO3 (130 mgs, 0.4 mmol) in acetone (2 mL) was stirred at 60° C. for 4 hours. After stirring the benzyl ether1 under an atmosphere of H2 (500 psi) in the presence of Pd/C (50 mg, 5%, Aldrich) in ethyl acetate (1 mL), EtOH (1 mL) and AcOH (1 drop) at 50° C. for 2 h, the product was purified by flash chromatography to give 36 mg of the product LL3 (0.043 mmol, 41% yield). 1H NMR (300 MHz, CDCl3): 7.25-7.48 (m, 10H, 7.02-7.15 (m, 6H), 6.85 (d, J=7 Hz, 2H), 5.92 (s, 2H), 3.91 (s br, 4H), 2.31 (s, 6H), 1.79 (s br, 4H), 1.31 (s, 36H).

Example 13

[0229] Building Block BB28:

[0230] According to Scheme B1 and General Procedure B1 Step 1, the in situ generated O-THP protected boronic acid BB20 (4.5 mmol), the protected 2-bromophenol building block BB2 (3.7 mmol, 1.64 g), Na2CO3 (3 mL of a 2 M solution in water, 6 mmol) and dimethoxy ethane (15 mL) were reacted in the presence of Pd(PPh3)3 (231 mg, 0.2 mmol) at 85° C. for 16 h. After cleavage of the THP ether and purification, 1.21 g of the product BB28 was obtained (2.66 mmol, 72% yield). 1H NMR (300 MHz, CDCl3): 8.15 (d br, J=7.5 Hz, 2H), 7.25-7.42 (m, 10H), 6.92-7.08 (m, 3H), 8.62 (t br, J=8 Hz, 2H), 6.23 (d br, J=7 Hz, 2H), 4.05 (s, 2H), 2.45 (s, 3H).

Example 14

[0231] Ligand LL4:

[0232] According to Scheme B1 and General Procedure B1 Step 2, a mixture of the phenol building block BB28 (490 mg, 1.077 mmol), 1,4-dibromobutane (116 mg, 0.54 mmol), and Cs2CO3 (489 mgs, 1.5 mmol) in acetone (5 mL) was stirred at 60° C. for 4 hours. After stirring the benzyl ethers under an atmosphere of H2 (500 psi) in the presence of Pd/C (50 mg, 5%, Aldrich) in ethyl acetate (1 mL), EtOH (1 mL) and AcOH (1 drop) at 50° C. for 2 h, the product was purified by flash chromatography to give 320 mg of the product LL4 (0.41 mmol, 38% yield). 1H NMR (300 MHz, CDCl3): 8.10 (d, J=8 Hz, 4H), 7.43 (dd, J=7.5 Hz, 2 Hz, 2H), 7.05-7.33 (m, 20H), 6,81 (dd, J=8 Hz, 0.5 Hz, 2H), 6.02 (d, 2H), 3.8 (s br, 4H), 2.33 (s, 6H), 1.68 (s br, 4H).

Example 15

[0233] Ligand LL5:

[0234] According to Scheme B1 and General Procedure B1 Step 2, a mixture of the phenol building block BB28 (1.202 g, 2.64 mmol), propane-1,3-diol-di-p-tosylate (506 mg, 1.32 mmol), Cs2CO3 (1.63 g, 5 mmol) in acetone (5 mL) was stirred at 60° C. for 16 hours. After stirring the benzyl ethers under an atmosphere of H2 (500 psi) in the presence of Pd/C (20 mg, 5%, Aldrich) in ethyl acetate (2 mL) and EtOH (2 mL) at 50° C. for 2 h, the product was purified by flash chromatography to give 630 mg of the product LL5 (0.82 mmol, 62%). 1H NMR (300 MHz, CDCl3): 8.18 (d, J=8 Hz, 4H), 7.09-7.39 (m, 18H), 6.88-9.95 (m, 4H), 6.30 (d, 2H), 5.55 (s, 2H), 3.95 (t, 4H), 2.35 (s, 6H), 2.14 (tt, 2H). 1H NMR (300 MHz, CDCl3): 8.18 (d, J=8 Hz, 4H), 7.09-7.39 (m, 18H), 6.88-9.95 (m, 4H), 6.30 (d, 2H), 5.55 (s, 2H), 3.95 (t, 4H), 2.35 (s, 6H), 2.14 (tt, 2H).

Example 16

[0235] Building Block BB29:

[0236] According to Scheme B1 and General Procedure B1 Step 1, the in situ generated O-THP protected aryl boronic acid BB20 (0.7 mmol), the protected 2-bromophenol building block BB9 (0.5 mmol, 226 mg), Na2CO3 (0.5 mL of a 2 M solution in water, 1 mmol) and dimethoxy ethane (7 mL) were reacted in the presence of Pd(PPh3)3 (80 mg, 0.07 mmol) at 85° C. for 16 h. After cleavage of the THP ether and purification, 135 mg of the product BB29 was obtained (0.29 mmol, 58% yield). 1H NMR (300 MHz, CDCl3): 8.45 (s, 1H), 8.05 (d, J=8.5 Hz, 2H), 7.75 (d, J=8.5 Hz, 2H), 7.22-7.45 (m, 10H), 7.02-7.10 (m, 2H), 6.95 (t, J=7.5 Hz, 1H), 6.80 (t, J=7 Hz, 2H), 6.05 (d, J=8 Hz, 2H), 4.05 (s, 2H), 2.48 (s, 3H).

Example 17

[0237] Ligand LL6:

[0238] According to Scheme B1 and General Procedure B1 Step 2, a mixture of the phenol building block BB29 (135 mg, 0.29 mmol), propane-1,3-diol-di-p-tosylate (56 mg, 0.146 mmol), and Cs2CO3 (196 mgs, 0.6 mmol) in acetone (2 mL) was stirred at 60° C. for 16 hours. After stirring the benzyl ether protected intermediate under an atmosphere of H2 (500 psi) in the presence of Pd/C (50 mg, 5%, 57% H2O, Johnson Mathey) in THF (1 mL) and EtOH (1 mL) at 50° C. for 2 h, the product was purified by flash chromatography (Ethylacetate/hexane=1/10) to give 50 mg of the product LL6 (0.062 mmol, 43%). 1H NMR (300 MHz, CDCl3): 7.35 (dd, J=7.5 Hz, 1.5 Hz, 2H), 7.18 (t, J=7.5 Hz, 2H), 7.05 (t, J=7.5 Hz, 2H), 6.99 (d, J=1.5 Hz, 2H), 6.85 (s, 2H), 6.81 (d, J=1.5 Hz, 2H), 6.72 (d, J=8 Hz, 2H), 4.0 (t, J=5.5 Hz, 4H), 2.70-2.80 (m, 8H), 2.35 (s, 6H), 2.18-2.46 (m, 4H), 2.02 (tt, J 5.5 Hz, 2H), 1.50-1.78 (m, 20H).

[0239] In another experiment, the benzyl ether protected intermediate was isolated in 80% yield. 1H NMR (300 MHz, CDCl3): 8.51 (s, 2H), 8.05 (d, J=7.5 Hz, 4H), 7.85 (d, J=7.5 Hz, 4H), 7.12-7.48 (m, 18H), 6.98 (t, J=7.5 Hz, 2H), 6.82 (t, J=7.5 Hz, 2H), 6.70 (t, J=7.5 Hz, 4H), 6.51 (d, J=8 Hz, 2H), 5.90 (d, J=7.5 Hz, 4H), 3.94 (s, 4H), 3.88 (t, 4H), 2.45 (s, 3H), 2.01-2.05 (m,2H).

[0240] Additional ligands synthesized in a manner similar to that described according to Scheme B1 include:

Example 18

[0241] Ligand LL25:

[0242] A mixture of the 2-bromophenol benzyl ether BB17 (319 mg, 0.84 mmol), the diboronic ester BB24 (604 mg, 1.26 mmol), K3PO4 (318 mg, 1.5 mmol) and DMF (5 mL) was degassed with argon. Pd(PPh3)3 (230 mg, 0.2 mmol, 10 mol %) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. After removal of the solvent in vacuo, the crude mixture was purified by flash chromatography to give 80 mg of the bridged intermediate. After stirring the benzyl ether intermediate under an atmosphere of H2 (500 psi) in the presence of Pd/C (20 mg, 5%, Aldrich) in THF (1 mL) and EtOH (1 mL) at 50° C. for 2 h, the product was purified by flash chromatography (Ethylacetate/hexane=1/10) to give 34 mg of the product LL25. 1H NMR (300 MHz, CDCl3): 7.32 (dd, J=7 Hz, 1 Hz, 2H), 7.21 (td, J=7.5 Hz, 1 Hz, 2H), 6.9-7.13 (m, 12H), 6.76 (d, J=7.5 Hz, 2H), 5.54 (s, 2H), 4.01 (t, J=6 Hz, 4H), 2.37 (s,6H), 2.31 (s, 6H), 2.13 (s, 6H), 2.03-2.5 (m, 2H).

Example 19

[0243] Detailed Example of 2-Br Substituted, Upper-Ring Protected, Lower Ring Deprotected Building Block Synthesized According to Scheme B3, Step 1:

[0244] To a solution of 690 mg (5.0 mmol) of 2-bromophenol-6-boronic acid and 1.70 g (4.95 mmol) of 2,6-dibromo-4-methylphenol benzyl ether in 15 mL of degassed dme was added 289 mg (0.25 mmol, 5 mol %) Pd(PPh3)4 and 3.2 mL of degassed 2.0 M aq. Na2CO3. After heating to 80° C. for 4 h, the reaction mixture was cooled to RT and poured into ether. Isolation and concentration of the organic layer, followed by column chromatography (silica gel, 10% ethyl acetate/hexanes eluent), provided 604 mg (33%) of pure product as a white solid. 1H NMR (300 MHz, CDCl3): 2.41 (s, 3H); 4.72 (s, 2H), 6.73 (s, 1H); 7.0-7.6 (overlapping multiplets, 11 H).

Example 20

[0245] Detailed Example of Bridged, Upper-Ring 2-Br Substituted Building Block Synthesized According to Scheme B3, Step 2:

[0246] To a solution of 604 mg (1.64 mmol) of 2-bromo-4-methyl-6-(2-hydroxyphenyl) phenol benzyl ether and 315 mg (0.82 mmol) of 1,3-propanediol di-p-tosylate in 10 mL of acetone was added 1.11 g (3.3 mmol) of Cs2CO3. After stirring at RT for 16 h, the soln. was filtered and the volitiles were removed. Column chromatography (silica gel, 10% ethyl acetate/hexanes eluent) provided 221 mg (35%) of the product as a white solid. 1H NMR (300 MHz, CDCl3): 1.96 (m, 2H); 2.35 (s, 6H); 3.91 (t, 4H); 4.52 (s, 4H), 6.8-7.6 (overlapping multiplets, 22 H).

Example 21

[0247] Detailed Example of a Ligand Synthesized According to Scheme B3, Step 3:

[0248] To a solution of 100 mg (0.13 mmol) of the dibromo building block described in Example 20 above dissolved in 5 mL of degassed dme was added 84 mg (0.51 mmol) of 2,4,6-trimethylphenylboronic acid, 15 mg (0.013 mmol, 10 mol %) of Pd(PPh3)4 and 150 μL of degassed 2.0 M aq. Na2CO3. After heating to 85° C. for 16 h, the reaction mixture was cooled to RT and poured into ether. Isolation and concentration of the organic layer, followed by column chromatography (silica gel, 5% ethyl acetate/hexanes eluent), provided 48 mg (42%) of the dibenzyl protected product as a white solid. 1H NMR (CDCl3): 1.88 (m, 2H); 2.10 (s, 12H); 2.34 (s, 6H); 2.35 (s, 6H); 3.81 (t, 4H); 4.21 (s, 4H), 6.3-7.6 (overlapping multiplets, 26 H).

[0249] After hydrogenation (200 psi H2, 50° C.) of the dibenzyl product in 5 mL of 1:1 EtOAc/EtOH with 50 mg 5% Pd/C catalyst for 3 h, purification by column chromatography (silica gel, 10% ethyl acetate/hexanes eluent) gave 27 mg (71%) of the ligand. 1H NMR (300 MHz , CDCl3): 2.0-2.1 (overlapped peaks, 14H); 2.30 (s, 6H); 2.34 (s, 6H); 4.02 (t, 4H); 5.40 (s, 2H); 6.7-7.6 (overlapping multiplets, 16 H).

Example 22

[0250] Additional Example of a Ligand Synthesized According to Scheme B3, Step 3:

[0251] Solutions of 141 μL of 2 M o-tolMgBr in THF and 141 μL of 0.5 M ZnCl2 in THF were combined in 1 mL of anhydrous THF and allowed to react at RT for 1 h. To this solution was added 55 mg (0.13 mmol) of the dibromo building block described in Example 20 above, and 1.0 mg (0.003 mmol, 2 mol %) of Pd(PtBu3)2. The mixture was diluted with 2 mL of THF and 1 mL of NMP, sealed, and heated to 80° C. for 2 h. After cooling to RT, the THF was removed in vacuo and the product was diluted with ether and washed with saturated brine. Isolation and concentration of the organic layer, followed by column chromatography (silica gel, 5% ethyl acetate/hexanes eluent), provided 39 mg (69%) of the dibenzyl protected product as a white solid. 1H NMR (CD2Cl2): 1.97 (m, 2H); 2.18 (s, 6H); 2.35 (s, 6H); 3.91 (m, 4H); 4.19 (s, 4H), 6.45 (d, 4H); 6.7-7.5 (overlapping multiplets, 26 H).

[0252] After hydrogenation (100 psi H2, 40° C.) of the dibenzyl product in 5 mL of 1:1 EtOAc/EtOH with 50 mg 5% Pd/C catalyst for 3 h, purification by column chromatography (silica gel, 10% ethyl acetate/hexanes eluent) gave 23 mg (77%) of the ligand. 1H NMR (300 MHz, CD2Cl2): 1.85 (m, 2H); 2.20 (s, 6H); 2.31 (s, 6H); 4.10 (t, 4H); 5.32 (s, 2H); 6.7-7.6 (overlapping multiplets, 20 H).

[0253] Part C: Synthesis of (S,S)-Bridged Bis(Biphenylphenol) Ligands:

Example 23

[0254] A biaryl Thiophenol Building Block Synthesized According to Scheme C1 Step 1:

[0255] A mixture of the S-THP protected boronic acid building block BB21 (7 mmol), the protected 2-bromophenol BB14 (5 mmol, 1.6 g), Na2CO3 (4 mL of a 2 M solution in water, 8 mmol) and dimethoxy ethane (15 mL) was degassed with argon (10 min). Pd(PPh3)3 (280 mg, 0.25 mmol, 5%) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. Ethyl acetate (EA, 15 mL) was added and the mixture was dried over Na2SO4. After filtration, the solvent was removed and the residue was dissolved in CH2Cl2 (10 mL). HCl (1 mL, 37%) was added and the resulting mixture was stirred at 40° C. for 2 h. Brine was added and the mixture was extracted with ethyl acetate, dried over Na2SO4, and purified by flash chromatography (Ethylacetate/hexane=1/10) to give 1.4 g of the product BB30 (4 mmol, 80% yield). 1H NMR (300 MHz, CDCl3): 7.58-7.63 (d br, J=7 Hz, 2H), 7.30-7.42 (m, 6H), 7.19-7.25 (m, 3H), 3.49 (s, 1H), 3.14 (s, 3H), 1.33 (s, 9H).

Example 24

[0256] A Bis Aryl Building Block Synthesized According to Scheme C1 Step 1:

100

[0257] According to Scheme C1 Step 1, the compound BB31 was synthesized in about 50% yield. 1H NMR (300 MHz, CDCl3): 7.56-7.63 (d br, J=7 Hz, 2H), 7.38-7.45 (m, 4H), 7.25-7.35 (m, 2H), 7.18-7.25 (m, 4H), 3.47 (s, 1H), 3.17 (s, 3H).

Example 25

[0258] A Ligand Synthesized According to Scheme C1 Step 2:

101

[0259] A mixture of the biaryl thiophenol building block BB31 (55 mg, 0.188 mmol), the corresponding dibromide (α,α′-dibromo-o-xylene, 25 mg, 0.094 mmol), and K2CO3 (55 mgs, 0.4 mmol) in acetone (2 mL) was stirred at 60° C. for 4 hours. After filtration, the solvent was removed and the residue was dissolved in CH2Cl2 (3 mL). BBr3 (1.5 mL of a 1 M solution in CH2CL2, 1.5 mmol) was added and the resulting mixture was stirred at room temperature for 2 h. Brine was added and the mixture was extracted with ethyl acetate, dried over Na2SO4, and purified by flash chromatography (Ethylacetate/hexane=1/10) to give 46 mg of the product LL26 (0.07 mmol, 75% yield). 1H NMR (300 MHz, CDCl3): 7.50-7.55 (d br, J=7 Hz, 4H), 7.41-7.48 (t br, J=7 Hz, 4H), 7.30-7.38 (m,4H), 7.23-7.29 (m, 8H), 6.98-7.08 (m, 8H), 3.95 (m, 4H).

[0260] Additional ligands that are synthesized in a manner similar to that described in Scheme C1:

102

103

104

105

106

Example 26

[0261] A Ligand Synthesized According to Scheme C2 Step 2:

107

[0262] A mixture of the protected bis aryl thiophenol (BB31) (104 mg, 0.356 mmol), the corresponding dibromide (1,2-dibromobenzene, 42 mg, 0.178 mmol), NaOtBu (48 mg, 0.5 mmol) in degassed toluene (2 mL) was added to a solution of Pd(dba)2 (20 mg, 0.036 mmol, 10%) and Xantphos (41 mg, 0.712 mmol, 20%), and the resulting mixture was stirred at 110° C. for 16 h under argon. After filtration, the solvent was removed and the residue was dissolved in CH2Cl2 (5 mL). BBr3 (2 mL of a 1 M solution in CH2CL2, 2 mmol) was added and the resulting mixture was stirred at room temperature for 2 h. Brine was added and the mixture was extracted with ethylacetate, dried over Na2SO4, and purified by flash chromatography (ethylacetate/hexane=1/10) to give 57 mg of the product LL42 (0.091 mmol, 51% yield). 1H NMR (300 MHz, CDCl3): 7.15-7.45 (m, 14H), 7.05-7.15 (m, 8H), 6.90 (t, J=7.5 Hz, 2H), 4.04 (s, 2H).

[0263] Additional ligands that are synthesized in a manner similar to that described in Scheme C2:

108

Example 27

[0264] A Ligand Synthesized by Combining Schemes C1 and C2:

109

[0265] According to Scheme C1 Step 2, the thiophenol building block BB31 (38 mg, 0.13 mmol), the corresponding dibromide (2-bromobenzylbromide, 33 mg, 0.13 mmol), and K2CO3 (110 mgs, 0.8 mmol) in acetone (2 mL) was stirred at 60° C. for 2 hours. After workup and cleavage of the methyl ethers, and purification 54 mg of the intermediate were isolated (0.117 mmol, 90%). According to Scheme C2 Step 2, a mixture of the thiophenol building block BB31 (34 mg, 0.117 mmol), the intermediate (54 mg, 0.117 mmol), NaOtBu (20 mg, 0.2 mmol), Pd(dba)2 (3 mgs, 0.006 mmol), and Xantphos (6 mg, 0.012 mmol) in toluene (2 mL) was stirred at 110° C. for 16 hours. After workup and cleavage of the methyl ethers, and purification 88 mg of the ligand LL45 was isolated (0.101 mmol, 54%). 1H NMR (300 MHz, CDCl3) (dimethyl ether!): 7.55-7.62 (m, 4H), 7.30-7.42 (m, 12H), 7.22-7.28 (m, 2H), 7.12-7.25 (m, 8H), 7.01-7.11 (m, 4H), 4.12 (m, 2H), 3.10 (s, 3H), 3.05 (s, 3H).

110

Example 28

[0266] A Ligand Synthesized According to Scheme C3:

111

[0267] A mixture of the boronic acid (0.8 mmol), the (S,S)-bridged bis (aryl bromide) (0.4 mmol, 161 mg, prepared as shown above), Na2CO3 (0.5 mL of a 2 M solution in water, 1.5 mmol) and dimethoxy ethane (5 mL) was degassed with argon (10 min). Pd(PPh3)4 (92 mg, 0.08 mmol, 20%) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. Ethyl acetate (15 mL) was added and the mixture was dried over Na2SO4. After filtration, the solvent was removed and the residue was dissolved in CH2Cl2 (10 mL). BBr3 (2 mL of a 1 M solution in CH2CL2, 2 mmol) was added and the resulting mixture was stirred at room temperature for 2 h. Brine was added and the mixture was extracted with EA, dried over Na2SO4, and purified by flash chromatography (Ethylacetate/hexane=1/10) to give 37 mg of the product LL46 (0.06 mmol, 15% yield). 1H NMR (300 MHz, CDCl3): 7.52-7.58 (d br, J=7 Hz, 4H), 7.41-7.48 (t br,J=7 Hz, 4H), 7.23-7.39 (m, 12H), 6.98-7.12 (m, 4H), 5.10 (s, 2H), 2.85 (s, 4H).

[0268] Additional ligands that are synthesized in a manner similar to that described in Scheme C3:

112

[0269] Part D:

Example 29

[0270] Synthesis of (O,S)-Bridged Bis(Biphenylphenol) Ligands:

113

[0271] A mixture of the MOM ether protected 2-bromophenol (176 mg, 0.43 mmol), the diboronic ester BB25 (110 mg, 0.216 mmol), K3PO4 (150 mg, 0.7 mmol) and DMF (2 mL) was degassed with argon. Pd(PPh3)4 (46 mg, 0.04 mmol) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. After removal of the solvent in vacuo, the crude mixture was purified by flash chromatography to give 81 mg of the intermediate. After cleavage of the MOM ether (HCl, THF, MeOH) and purification, 40 mg of the product LL49 was obtained (0.05 mmol, 23% yield). 1H NMR (300 MHz, CDCl3): 8.10 (d, J=7.5 Hz, 4H), 7.15-7.45 (m, 21H), 7.05-7.12 (m, 2H), 6.88 (d, J=8.5 Hz, 1 H), 6.01 (s, 1H), 4.89 (s, 1H), 3.95 (t, J=6 Hz, 2H), 2.75 (t, J=7 Hz, 2H), 2.37 (s, 3H), 2.32 (s, 3H), 1.75-1.85 (m, 2H), 1.60-1.70 (m, 2H).

[0272] Part E: Synthesis of (N,N)-Bridged Bis(Biphenylphenol) Ligands:

Example 30

[0273] Synthesis of Bis Aryl Building Blocks BB32 and BB33:

114

[0274] n-BuLi (2.6 mmol, from a 1.6 M solution in hexanes) was added slowly to a solution of the benzyl ether protected 2-bromophenol (2.47 mmol) in THF (5 mL, anhydrous) at −78° C. under an atmosphere of argon. After stirring for 10 min at that temperature, triisopropyl borate (645 μL, 2.8 mmol) was added slowly and the temperature was allowed to come to room temperature (30 min). After stirring for another 30 min, the solvent was removed and the crude boronic acid was used without further purification. A mixture of the boronic acid (750 mg, 2.5 mmol), 1,2 dibromobenzene (2.36 g, 10 mmol), Na2CO3 (2 mL of a 2 M solution in water, 4 mmol) and dimethoxy ethane (15 mL) was degassed with argon. Pd(PPh3)3 (144 mg, 0.125 mmol, 10%) was added and the resulting mixture was stirred at 85° C. for 16 h under argon. Ethyl acetate (30 mL) was added and the mixture was dried over Na2SO4. After filtration, the crude product was purified by flash chromatography (ethylacetate/hexane=1/10) to give 762 mg of the benzyl ether product BB32 (1.6 mmol, 65% yield). The methyl ether product BB33 was prepared similarly.

Example 31

[0275] Synthesis of (NH,NH)-Bridged Biaryl Phenyl Methyl Ether Ligand:

115

[0276] A mixture of the methyl ether building block BB33 (140 mg, 0.348 mmol), 1,4-diaminobutane (15 mg, 0.174 mmol), NaOtBu (48 mg, 0.5 mmol) and toluene (2 mL) was degassed with argon. Pd(dba)2 (9 mg, 0.015 mmol) and dppf (1,1′-bis(diphenylphosphino)ferrocene, 17 mg, 0.03 mmol) were added and the resulting mixture was stirred at 100° C. for 16 h under argon. After removal of the solvent in vacuo, the crude mixture was purified by flash chromatography to give 51 mg of the product LL50 (0.068 mmol, 39% yield). 1H NMR (300 MHz, CDCl3): 7.82-7.90 (m, 4H), 7.61-7.79 (m, 2H), 7.32-7.55 (m, 8H), 7.21-7.29 (m, 4H), 7.09-7.19 (m, 4H), 6.65-6.89 (m, 4H), 3.90-4.05 (m, 2H), 3.05-3.15 (m, 4H), 2.95 (t, 6H), 2.33 (s, 6H), 1.62-1.80 (m,4H).

Example 32

[0277] Synthesis of (NMe,NMe)-Bridged Biaryl Phenol Ligand LL51:

116

[0278] A mixture of the substituted phenylbromide (benzyl ether, BB32, 133 mg, 0.278 mmol), 1,4-diaminobutane (12 mg, 0.139 mmol), NaOtBu (48 mg, 0.5 mmol) and toluene (2 mL) was degassed with argon. Pd(dba)2 (9 mg, 0.015 mmol) and dppf (17 mg, 0.03 mmol) were added and the resulting mixture was stirred at 100° C. for 16 h under argon. After removal of the solvent in vacuo, the crude mixture was purified by flash chromatography to give 31 mg of the intermediate. A mixture of this intermediate with formic acid (0.5 mL) and paraformaldehyde (0.5 mL of a 37% solution in H2O) was stirred for 30 min at 80° C. Na2CO3 (5 mL of a 2M aq. Solution) was added and the mixture was extracted with ethyl acetate. After stirring the benzyl ether intermediate under an atmosphere of H2 (500 psi) in the presence of Pd/C (50 mg, 5%, Aldrich) in EA (1 mL), EtOH (1 mL) at 50° C. for 2 h, the crude product was purified by flash chromatography to give 15 mg of the product LL51. 1H NMR (300 MHz, CDCl3): 10.23 (s, 2H), 7.82 (t, 4H), 7.62 (d, 2H), 6.42-7.52 (m, 4H), 7.15-7.41 (m, 14H), 7.08 (t, 2H), 7.02 (d, 2H), 2.42-2.60 (m, 10H), 2.30 (s, 3H), 2.25 (s, 3H), 1.42-1.12 (m, 4H).

[0279] Complexes used in some of the examples:

117

118

Example 33

[0280] Synthesis of Complex C1:

[0281] 46.3 mg (67 umol) LL1 in 6 mL toluene were combined with 36.3 mg (67 umol) of HfBz4 in 6 mL toluene. The mixture was stirred for 10 min and slowly concentrated by removing the solvent with a stream of inert gas. A white solid material was isolated. The 1H-NMR is consistent with one symmetrical compound. The 1H-NMR spectrum indicates the presence of toluene in the isolated product. 1H-NMR in C6D6 (δ in ppm): aromatic protons: 7.83 (d), 7.6-6.5 (m), 6.05 (d) bridge CH2—O— protons 4.1 (m), 3.6 (m) Hf—CH2Ph protons: 2.21 (d), 1.1 (d) tBu protons: 1.24 (s), bridge CH2—CH2—O— protons 0.83 (m), 0.45 (m).

Example 34

[0282] Synthesis of Complex C2:

[0283] 50 mg (64.85 umol) LL5 and 23 mg Hf(NMe2)4 were combined in 8 mL toluene. The reaction mixture was placed in sand bath at 60-70° C. After 1 hour, a stream of Ar was used to remove the solvent. A dry white product was obtained. The 1H-NMR is consistent with a C2 symmetric bisamide complex and indicates the presence of toluene in the isolated product. 1H-NMR in C6D6 (δ in ppm): 8.39 (d), 8.09 (d), 7.5-6.6 (m), 5.02 (d), 3.8 (m), 3.25 (m), 2.15 (s), 1.82 (s), 1.05 (m).

Example 35

[0284] Synthesis of Complex C3:

[0285] 64 umol of complex C2 is dissolved in 5 mL toluene and 100 mg of Me3Si—Cl was added. After reaction overnight, volatile products and the solvent were removed. The reaction mixture was taken up in 2 ml toluene and 400 ul Cl2SiMe2 were added. A white precipitate formed within 30 min. 31 mg (45%) of the bischloride complex 3 was isolated. The 1H-NMR is consistent with one C2 symmetric bischloride complex (on NMR timescale) and indicates the presence of toluene in the isolated product. 1H-NMR in CD2Cl2 (δ in ppm): 8.38 (d), 8.12 (d), 7.6-7.05 (m), 6.75 (m), 4.61 (d), 4.21 (m), 3.7 (m), 2.4 (s), 1.72 (m).

Example 36

[0286] Synthesis of Complex C3:

[0287] 31.4 umol ligand LL5 is dissolved in 450 ul toluene. 31.6 umol HfCl2Bz2.Et2O is dissolved in 900 ul toluene and added to the ligand solution. The reaction mixture was placed in a sand bath at 70° C. for 1 hour. The reaction mixture was allowed to cool to room temperature overnight. The supernatant liquid was removed from the white solid product. The solid material was dried. Yield: 25 umol (80%).

Example 37

[0288] Synthesis of Complex C4:

[0289] 37.6 mg (54 umol) LL1 in 8 mL toluene was combined with 24.8 mg (54 umol) of ZrBz4 in 6 mL toluene. The mixture was stirred for 1-2 min and slowly concentrated by removing the solvent with a stream of inert gas. A pale yellow solid material was isolated. The 1H-NMR is consistent with one symmetrical compound. The 1H-NMR spectrum indicates the presence of toluene in the isolated product. 1H-NMR in C6D6 (δ in ppm): aromatic protons: 7.91 (d), 7.7-6.6 (m), 6.07 (d) bridge CH2—O— protons 4.02 (m), 3.54 (m) Hf—CH2Ph protons: 2.46 (d), 1.24 (d) tBu protons: 1.17 (s) , bridge CH2—CH2—O— protons 0.86 (m), 0.51 (m).

Example 38

[0290] Synthesis of Complex C5:

[0291] 12.1 mg HfCl2Bz2.Et2O (24 umol) in 900 uL toluene was added to 20.4 mg LL6 (25 umol) in 450 uL toluene. 150 uL toluene were added and the reaction mixture was placed in a sand bath at 80° C. for 1.5 hours. The solution was allowed to cool to room temperature. Colorless crystals formed which were isolated by decanting the supernatent liquid. Yield 14.4 mg (54%). 1H-NMR in CD2Cl2 (δ in ppm): 7.7-6.9 ppm (aromatic protons), 6.1 ppm (d), 4.25 (m), 4.05 (m), 3.1-2.6 (m), 2.6-2.05 (m), 2.05-1.3 (m). Single crystal X-ray analysis was performed. Crystallographic data: for C57H58Cl2HfO4, M=1056.42. Orthorombic crystal system, space group Pcca, unitcell dimentions: a=22.851(10) Å, b=14.984(5) Å, c=16.454 (7) Å, Z=4, Dc=1.253 mg/m3, 15684 reflections collected. The structure was solved by by direct methods and refined by full-matrix least squares on F2. The final refinement converged at R1=0.0815 and wR2=0.2011 for I>2σ (I) and R1=0.1561 and wR2=0.2206 for all data. X-ray structure is shown in FIGS. 1a and 1b.

Example 39

[0292] Synthesis of Complex C6:

[0293] 16 mg HfCl2Bz2.Et2O (31.7 umol) in 800 uL toluene was added to 26 mg (31.7 umol) LL3 in 400 uL toluene. The reaction mixture was placed in a sand bath at 70° C. for 35 min. The reaction mixture was allowed to cool to room temperature over night and was cooled to −30° C. for 1 hour. The colorless crystalline material was separated from the solution and dried. Yield: 30 mg (87%). 1H-NMR in CD2Cl2 (δ in ppm): 7.64-7.02 ppm (aromatic protons), 4.62 (m), 3.94 (m), 2.36 (s), 1.40 (s), 1.20 (m).

Example 40

[0294] Synthesis of Complex C7:

[0295] 11.3 mg HfCl2Bz2.Et2O (22.3 umol) in 500 uL toluene was added to 18 mg (22.3 umol) LL52 in 300 uL toluene. The reaction mixture was placed in a sand bath at 70° C. for 90 min. The reaction mixture was allowed to cool to room temperature for 100 min and was cooled to −30° C. over night. The powdery crystalline material was separated from the solution and dried. Yield: 14.3 mg (61%). 1H-NMR in CD2Cl2 (δ in ppm): 8.36 (d), 8.12 (d), 7.5-7.0 ppm (aromatic protons), 4.44 (m), 4.52 (m), 4.15 (m), 3.67 (m), 2.40 (s), 1.7 (m).

Example 41

[0296] Propylene polymerizations using metal-ligand compositions. A total of one hundred and eight (108) separate polymerization reactions were performed as described herein.

[0297] Preparation of the polymerization reactor prior to injection of catalyst composition: A pre-weighed glass vial insert and disposable stirring paddle were fitted to each reaction vessel of the reactor. The reactor was then closed, 0.10 mL of a 0.02 M solution of group 13 reagents in toluene and 3.9 mL of toluene were injected into each pressure reaction vessel through a valve. The identity of the group 13 reagent solution is given in Tables 1-3. The temperature was then set to the appropriate setting (with specific temperatures for each polymerization being listed in Tables 1-3, below), and the stirring speed was set to 800 rpm, and the mixture was exposed to propylene at 100 psi pressure. A propylene pressure of 100 psi in the pressure cell and the temperature setting were maintained, using computer control, until the end of the polymerization experiment.

[0298] In situ preparation of metal-ligand compositions: The following methods were employed to prepare the metal-ligand compositions as indicated in the Tables 1-3. Method A: An appropriate amount of ligand solution (10 mM in toluene) was dispensed in a 1 mL glass vial at a scale of 0.4-0.75 mmol. To the 1 mL glass vial containing the ligand solution was added an equimolar amount of metal precursor solution (10 mM in toluene) to form the metal-ligand composition solution. The reaction mixture was heated to 70-80° C. for 1-2 hours. Method B: Similar to Method A except the reaction mixture was heated to 60° C. for 1-2 hours. Method C: Similar to Method A except the reaction mixture was heated to 80° C. for 1-2 hours. The residual solvent and volatile byproducts were removed by blowing a stream of Argon over the 1 mL vial. The composition was redissolved in toluene prior to addition of alkylation and activator solution. Method D: Similar to Method A except the concentration of ligand and metal precursor solutions were 5 mM. The reaction mixture was allowed to sit at room temperature for 35 min and than was heated to 70-80° C. for 10 min. Method E: Similar to Method B except the concentration of ligand and metal precursor solutions were 5 mM. Method F: Similar to Method A except the concentration of ligand solution was 5 mM and metal precursor solution was 10 mM. The reaction mixture was heated for 30 min to 50° C. Method G: Similar to Method A except the concentration of ligand solution was 15 mM and metal precursor solution was 10 mM. The reaction mixture was heated for 1 hour to 70° C. Method H: Similar to Method A except the concentration of ligand solution was 60 mM and metal precursor solution was 5 mM. The reaction mixture was heated for 45 min to 70° C. Method I: Similar to Method G except the concentration of ligand solution was 25 mM and metal precursor solution was 5 mM. Method J: Similar to Method H except the concentration of ligand solution was 12 mM and metal precursor solution was 5 mM.

[0299] Preparation of the group 13 reagent and activator stock solutions: The “activator solution” is a solution of N,N′-dimethylanilinium tetrakis (pentafluorophenyl) borate in toluene (“ABF20”). The molarity of this solution is indicated in the “activation method” of the individual example described below. The solution is heated to approximately 85° C. to dissolve the reagent. The “group 13 reagent” solution is either a solution of triisobutyl aluminium (“TIBA”) or a solution of trimethylaluminium (“TMA”) or a solution of Modified Methylaluminoxane 3A (from Azko Chemical Inc., Chicago, Ill.) (“MMAO”) or a solution of Polymethylaluminoxane-Improved Process (from Azko Chemical Inc., Chicago, Ill.) (“PMAO”), all “group 13 reagent” solutions were solutions in toluene. The molarity of the solutions used is indicated in the “activation method” of the individual example described below.

[0300] Activation methods and Injection of solutions into the pressure reactor vessel, The following methods were employed to activate and inject the metal-ligand compositions for the examples in the Tables 1-3. Method AA: To the metal-ligand composition, 20 mole equivalents (per metal precursor) of a 500 mM solution of 1-octene in toluene were added to the metal ligand composition in the 1 mL vial. Then, the appropriate amount of the group 13 reagent solution as a 50 mM solution, containing the indicated equivalents group 13 reagent (per metal precursor) in the specific example, was added to the 1 mL vial. After 45 sec, 1.1 mol equivalents (per metal precursor) of the “activator solution” (2.5 mM) was added to the 1 mL vial. About another 30 seconds later, a fraction of the 1 mL vial contents corresponding to the indicated “catalyst amount injected” was injected into the prepressurized reaction vessel and was followed immediately by injection of toluene to bring the total volume injected to 0.400-0.500 mL. Method BB: similar to Method AA except the concentration of the activator solution was 5 mM. Method CC: To the metal-ligand composition, the appropriate amount of the group 13 reagent solution as a 50 mM solution, containing the indicated equivalents group 13 reagent (per metal precursor) in the specific example, was added to the 1 mL vial. After 40 sec, the indicated amount of the “activator solution” (2.5 mM) was added to the 1 mL vial. About another 40 seconds later, a fraction of the 1 mL vial contents corresponding to the indicated “catalyst amount injected” was injected into the prepressurized reaction vessel, and was followed immediately by injection of toluene to bring the total volume injected to 0.400-0.500 mL. Method DD: To the metal-ligand composition, the appropriate amount of the group 13 reagent solution (50 mM), containing the indicated equivalents group 13 reagent (per metal precursor) in the specific example, was added to the 1 mL vial that was kept at 50-60° C. After about 10 min, the indicated amount of the “activator solution” (2.5 mM) was added to the 1 mL vial. About another 70 seconds later, a fraction of the 1 mL vial contents containing the indicated “catalyst amount injected” was injected into the prepressurized reaction vessel and was followed immediately by injection of toluene to bring the total volume injected to 0.400-0.500 mL.

[0301] Polymerization: The polymerization reaction was allowed to continue for 60-900 seconds, during which time the temperature and pressure were maintained at their pre-set levels by computer control. The specific polymerization times for each polymerization are shown in Tables 1-3. After the reaction time elapsed, the reaction was quenched by addition of an overpressure of carbon dioxide sent to the reactor. The polymerization times were the lesser of the maximum desired polymerization time or the time taken for a predetermined amount of monomer gas to be consumed in the polymerization reaction.

[0302] Product work up: Propylene Polymerizations: After the polymerization reaction, the glass vial insert, containing the polymer product and solvent, was removed from the pressure cell and removed from the inert atmosphere dry box, and the volatile components were removed using a centrifuge vacuum evaporator. After most of the volatile components had evaporated, the vial contents were dried thoroughly by evaporation at elevated temperature under reduced pressure. The vial was then weighed to determine the yield of polymer product. The polymer product was then analyzed by rapid GPC, as described above to determine the molecular weight of the polymer produced, and by FTIR spectroscopy to determine the crystallinity index. The melting point of selected samples was measured by DSC, as described above.

2TABLE 1Group 13catalystActivityMpreagentActivatoracti-amountPolym.(g polymer/DSCMwMetalcomplexationand moleand molvationinjectedtemp.Polym.(min *FTIRdata ((/1000)Ligandprecursormethodequiv.equiv.methodnmol(Celsius)time (sec)mmol)indexCelsius)(PDI)LL5HfBz4A6 MMAO1.1 ABF20BB501107646830.8128 333 (2.0)LL5HfBz4A6 MMAO1.1 ABF20BB1001308923790.82 151 (1.9)LL5ZrBz4A6 MMAO1.1 ABF20BB5011018210790.76108 106 (1.6)LL5ZrBz4A6 MMAO1.1 ABF20BB1001302984990.68 82 (1.5)LL5TiBz4F5 PMAO1.1 ABF20BB20090600130.5 979 (1.9)LL4HfBz4A6 MMAO1.1 ABF20BB5011017914700.861371116 (1.7)LL4HfBz4A6 MMAO1.1 ABF20BB1001302107200.88 407 (1.7)LL4ZrBz4A6 MMAO1.1 ABF20BB501103754490.82 271 (1.6)LL4ZrBz4A6 MMAO1.1 ABF20BB1001306011280.82 135 (1.7)LL14HfBz4F5 PMAO1.1 ABF20BB15090600180.82 404 (1.7)LL14ZrBz4F5 MMAO1.1 ABF20BB15090600170.63ndLL18HfBz4A6 MMAO1.1 ABF20CC601109428660.84 407 (2.0)LL18HfBz4A6 MMAO1.1 ABF20CC6013011421360.84 266 (2.1)LL18ZrBz4A6 MMAO1.1 ABF20CC601102017670.74 122 (1.8)LL18Zr(NMe2)4C10 TMA1.1 ABF20DD1001101119920.74 123 (1.7)LL21HfBz4A6 MMAO1.1 ABF20CC401109150480.86134 526 (2.5)LL21HfBz4A6 MMAO1.1 ABF20CC601309229080.86133 181 (2.2)LL21ZrBz4A6 MMAO1.1 ABF20CC6011012813660.77 232 (1.8)LL21ZrBz4A6 MMAO1.1 ABF20CC1001302578140.77 117 (1.8)LL23HfBz4A6 MMAO1.1 ABF20CC6011010826640.84 368 (2.0)LL23ZrBz4A6 MMAO1.1 ABF20CC601102506600.73 118 (1.8)LL20HfBz4A6 MMAO1.1 ABF20CC601106001450.912764 (1.5)LL20ZrBz4A6 MMAO1.1 ABF20CC601104883760.76 627 (1.6)LL49HfBz4A6 MMAO1.1 ABF20CC7575900460.871678 (2.5)LL49ZrBz4A6 MMAO1.1 ABF20CC75756261030.89 24 (1.5)

[0303]

3

TABLE 2

Group 13

catalyst

Activity

reagent
Activator
acti-
amount
Polym.
Polym.
(g polymer/

Mp DSC
Mw

Metal
complexation
and mole
and mol
vation
injected
temp.
time
(min *
FTIR
data
(/1000)

Ligand
precursor
method
equiv.
equiv.
method
nmol
(Celsius)
(sec)
mmol)
index
(Celsius)
(PDI)

LL1
HfBz4
A
5 MMAO
1.1 ABF20
AA
50
90
133
1973
0.32

416 (1.6)

LL1
ZrBz4
A
5 MMAO
1.1 ABF20
AA
50
90
260
681
0.60

577 (1.6)

LL1
HfBz4
A
5 MMAO
1.1 ABF20
BB
100
110
293
295
0.57

184 (1.8)

LL1
ZrBz4
A
5 MMAO
1.1 ABF20
BB
100
110
126
930
0.30

162 (1.9)

LL7
HfBz4
A
5 MMAO
1.1 ABF20
BB
100
110
141
758
0.78

378 (1.8)

LL7
ZrBz4
A
5 MMAO
1.1 ABF20
BB
100
110
165
536
0.65

203 (1.9)

LL2
HfBz4
A
6 MMAO
1.1 ABF20
CC
75
110
900
83
0.92
146
123 (1.6)

LL2
HfBz4
A
6 MMAO
1.1 ABF20
CC
60
75
489
265
0.89
151
781 (1.8)

LL2
ZrBz4
A
6 MMAO
1.1 ABF20
CC
75
110
163
785
0.89
137
113 (1.5)

LL2
ZrBz4
A
6 MMAO
1.1 ABF20
CC
60
75
149
1643
0.87
142
393 (1.6)

LL3
HfBz4
A
6 MMAO
1.1 ABF20
CC
150
110
494
123
0.95
149
197 (2.1)

LL3
HfBz4
A
6 MMAO
1.1 ABF20
CC
60
75
602
153
0.93
153
977 (1.8)

LL3
ZrBz4
A
6 MMAO
1.1 ABF20
CC
60
110
900
91
0.90
142
298 (1.8)

LL10
HfBz4
A
6 MMAO
1.1 ABF20
CC
150
110
900
30
0.93
149
202 (2.4)

LL10
ZrBz4
A
6 MMAO
1.1 ABF20
CC
60
110
900
38
0.89
139
322 (2.2)

LL53
HfBz4
B
6 MMAO
1.1 ABF20
CC
150
110
485
111
0.93

122 (1.5)

LL53
ZrBz4
B
6 MMAO
1.1 ABF20
CC
150
110
124
629
0.92

85 (1.6)

LL54
HfBz4
B
6 MMAO
1.1 ABF20
CC
150
110
153
449
0.94

99 (1.5)

LL54
ZrBz4
B
6 MMAO
1.1 ABF20
CC
150
110
104
744
0.91

106 (1.6)

LL6
HfBz4
A
6 MMAO
1.1 ABF20
CC
75
110
900
105
0.89
146
526 (1.9)

LL6
HfBz4
A
6 MMAO
1.1 ABF20
CC
60
75
900
107
0.90
150
1969 (1.7)

LL6
ZrBz4
A
6 MMAO
1.1 ABF20
CC
75
110
709
152
0.86
135
164 (1.5)

LL6
ZrBz4
A
6 MMAO
1.1 ABF20
CC
60
75
209
598
0.90
139
317 (1.5)

LL6
Hf(NMe2)4
C
10 TMA
1.1 ABF20
DD
150
110
126
687
0.91

197 (1.8)

LL6
Hf(NMe2)4
C
10 TMA
1.1 ABF20
DD
150
110
96
966
0.87

109 (1.5)

LL12
HfBz4
B
6 MMAO
1.1 ABF20
CC
150
110
675
102
0.76

87 (1.5)

LL12
ZrBz4
B
6 MMAO
1.1 ABF20
CC
150
110
112
635
0.56

98 (1.6)

LL13
HfBz4
B
6 MMAO
1.1 ABF20
CC
150
110
901
29
0.78

83 (1.6)

LL13
ZrBz4
B
6 MMAO
1.1 ABF20
CC
150
110
117
649
0.60

109 (1.5)

LL9
HfBz4
D
5 PMAO
1.1 ABF20
BB
100
110
600
81
0.65

56 (1.8)

LL9
ZrBz4
E
5 PMAO
1.1 ABF20
BB
100
110
129
803
0.47

91 (1.5)

LL8
HfBz4
D
5 PMAO
1.1 ABF20
BB
100
110
600
74
0.66

156 (1.6)

LL8
ZrBz4
E
5 PMAO
1.1 ABF20
BB
100
110
194
460
0.48

144 (1.5)

LL25
HfBz4
A
6 MMAO
1.1 ABF20
CC
60
75
617
150
0.77

674 (1.8)

LL25
ZrBz4
A
6 MMAO
1.1 ABF20
CC
60
75
159
1172
0.65

144 (2.2)

[0304]

4

TABLE 3

Group 13

catalyst

Activity

reagent
Activator
acti-
amount
Polym.

(g polymer/

Mp DSC
Mw

Metal
complexation
and mole
and mol
vation
injected
temp.
Polym.
(min *
FTIR
data
(/1000)

Ligand
precursor
method
equiv.
equiv.
method
nmol
(Celsius)
time (sec)
mmol)
index
(Celsius)
(PDI)

LL46
TiBz4
G
5 MMAO
1.1 ABF20
AA
300
90
900
8
0.51

103 (2.5)

LL46
ZrBz4
G
5 MMAO
1.1 ABF20
AA
200
110
650
22
0.63

35 (2.7)

LL46
HfBz4
H
5 MMAO
1.1 ABF20
AA
150
90
314
98
0.75

25 (2.0)

LL37
ZrBz4
I
5 MMAO
1.1 ABF20
AA
75
90
900
46
0.78

5 (1.4)

LL37
ZrBz4
J
5 TIBA
1.1 ABF20
AA
75
90
900
36
0.72

4 (3.3)

LL48
ZrBz4
H
5 MMAO
1.1 ABF20
AA
150
90
113
417
0.57

12 (2.2)

LL48
HfBz4
H
5 MMAO
1.1 ABF20
AA
300
90
138
192
0.69

102 (2.9)

LL48
ZrBz4
G
5 MMAO
1.1 ABF20
AA
200
110
189
170
0.52

41 (2.5)

LL48
HfBz4
G
5 MMAO
1.1 ABF20
AA
200
110
312
86
0.50

49 (4.1)

LL31
ZrBz4
I
5 MMAO
1.1 ABF20
AA
75
90
323
261
0.49

2 (1.2)

LL31
HfBz4
I
5 MMAO
1.1 ABF20
AA
150
90
304
148
0.69

11 (1.7)

LL31
ZrBz4
J
5 TIBA
1.1 ABF20
AA
75
90
358
218
0.43

3 (2.6)

LL31
HfBz4
J
5 TIBA
1.1 ABF20
AA
75
90
651
127
0.57

18 (4.2)

LL28
ZrBz4
H
5 MMAO
1.1 ABF20
AA
150
90
80
885
0.52

28 (2.0)

LL28
HfBz4
H
5 MMAO
1.1 ABF20
AA
300
90
62
779
0.59

93 (1.9)

LL28
ZrBz4
G
5 MMAO
1.1 ABF20
AA
200
110
105
320
0.46

35 (2.7)

LL28
HfBz4
G
5 MMAO
1.1 ABF20
AA
200
110
92
455
0.51

80 (2.9)

LL29
ZrBz4
A
5 MMAO
1.1 ABF20
AA
50
90
160
855
0.51

19 (1.9)

LL29
HfBz4
A
5 MMAO
1.1 ABF20
AA
50
90
358
437
0.42

115 (1.6)

LL30
ZrBz4
I
5 MMAO
1.1 ABF20
AA
75
90
154
663
0.38

42 (2.0)

LL30
HfBz4
I
5 MMAO
1.1 ABF20
AA
150
90
193
184
0.45

104 (2.0)

LL30
ZrBz4
J
5 TIBA
1.1 ABF20
AA
75
90
166
592
0.38

51 (4.2)

LL30
HfBz4
J
5 TIBA
1.1 ABF20
AA
75
90
636
215
0.36

132 (6.3)

LL30
HfBz4
J
5 PMAO
1.1 ABF20
AA
150
110
208
136
0.39

49 (4.9)

LL38
ZrBz4
I
5 MMAO
1.1 ABF20
AA
75
90
163
624
0.74

6 (1.5)

LL38
ZrBz4
I
5 PMAO
1.1 ABF20
AA
75
90
116
809
0.73

6 (1.5)

LL38
TiBz4
I
5 MMAO
1.1 ABF20
AA
300
90
900
11
0.63

533 (1.5)

LL38
TiBz4
I
5 PMAO
1.1 ABF20
AA
300
90
900
12
0.63

605 (1.9)

LL38
HfBz4
I
5 MMAO
1.1 ABF20
AA
150
90
75
1579
0.75

56 (2.0)

LL38
HfBz4
I
5 PMAO
1.1 ABF20
AA
100
90
99
1421
0.74

59 (1.9)

LL39
ZrBz4
A
5 MMAO
1.1 ABF20
AA
50
90
901
112
0.39

5 (1.4)

LL39
HfBz4
A
5 MMAO
1.1 ABF20
AA
50
90
901
62
0.23

34 (1.5)

LL40
ZrBz4
A
5 MMAO
1.1 ABF20
AA
100
90
372
152
0.94

9 (1.5)

LL40
TiBz4
A
5 MMAO
1.1 ABF20
AA
300
90
900
13
0.86

38 (1.8)

LL40
HfBz4
A
5 MMAO
1.1 ABF20
AA
50
90
154
1120
0.95

103 (1.4)

LL32
ZrBz4
I
5 PMAO
1.1 ABF20
AA
75
90
124
981
0.52

47 (2.3)

LL32
HfBz4
I
5 PMAO
1.1 ABF20
AA
100
90
128
776
0.67

131 (1.7)

LL45
ZrBz4
H
5 MMAO
1.1 ABF20
AA
150
90
227
123
0.21

3 (1.2)

LL45
HfBz4
H
5 MMAO
1.1 ABF20
AA
300
90
150
156
0.24

8 (1.6)

LL45
TiBz4
G
5 MMAO
1.1 ABF20
AA
300
90
900
19
0.61

2601 (2.9)

LL26
ZrBz4
H
5 MMAO
1.1 ABF20
AA
150
90
672
46
0.35

9 (1.7)

LL26
HfBz4
H
5 MMAO
1.1 ABF20
AA
300
90
900
18
0.27

25 (1.9)

LL27
ZrBz4
H
5 MMAO
1.1 ABF20
AA
150
90
312
114
0.70

36 (2.6)

LL27
HfBz4
H
5 MMAO
1.1 ABF20
AA
300
90
107
259
0.74

179 (1.8)

LL33
ZrBz4
I
5 MMAO
1.1 ABF20
AA
75
90
349
231
0.57

31 (1.9)

LL33
HfBz4
I
5 MMAO
1.1 ABF20
AA
150
90
255
169
0.57

165 (1.9)

LL43
ZrBz4
H
5 MMAO
1.1 ABF20
AA
150
90
900
16
0.49

56 (8.0)

LL43
HfBz4
H
5 MMAO
1.1 ABF20
AA
300
90
900
7
0.50

nd

Example 42

[0305] Propylene Polymerizations using isolated complexes. A total of thirty-three (33) separate polymerization reactions were performed as described herein:

[0306] Preparation of the polymerization reactor prior to injection of catalyst composition: The polymerization reactor was prepared in the manner described in Example 41.

[0307] Preparation of the group 13 reagent and activator stock solutions: The “activator solution” is either a solution of N,N′-dimethylanilinium tetrakis (pentafluorophenyl) borate in toluene (“ABF20”) or a solution of tris(pentafluorophenyl) borane in toluene (“BF15”). The “ABF20” solution is heated to approximately 85° C. to dissolve the reagent. The molarity is indicated in the “activation method” of the individual example described below. The “group 13 reagent” solution is either a solution of triisobutyl aluminium (“TIBA”) or a solution of trimethylaluminium (“TMA”) or a solution of triethylaluminium (“TEAL”) or a solution of diisobuthylaluminium hydride (“DIBAL”) or a solution of Modified Methylaluminoxane 3A (Azko Chemical Inc., Chicago, Ill.) (“MMAO”) or a solution of Polymethylaluminoxane-Improved Process (Azko Chemical Inc., Chicago, Ill.) (“PMAO”), all “group 13 reagent” solutions were solutions in toluene. The molarity of the solutions used is indicated in the “activation method” of the individual example described below.

[0308] Activation method and Injection of solutions into the pressure reactor vessel: The following methods were employed to activate and inject the isolated complexes as indicated in the Table 4. Method II: An appropriate amount of a 0.050M solution of the group 13 reagent, containing the indicated equivalents group 13 reagent (per isolated complex) in the specific examples in Table 4, is dispensed into a 1 mL vial. An appropriate amount complex solution (3-4 mM in dichloroethylene) containing 0.4 umol metal complex is added. After 10 min, 0.44 umol of the activator solution in toluene (2.5 mM) was added to the 1 mL vial. About another 60 seconds later a fraction of the total 1 mL vial contents containing the indicated “catalyst amount injected” being identified in Table 4 was injected into the pre-pressurized reaction vessel and was followed immediately by injection of toluene to increase the total volume injected of 0.400 mL. Method JJ: similar to Method II except that the concentration of the group 13 reagent solution was 0.200 M. Method KK: similar to Method JJ except that the 1 mL vial was heated to 50-60° C. Method LL: 40 uL of the 10 mM complex solution in toluene is dispensed into a 1 mL vial. An appropriate amount based on the equivalents presented in table 4 of a 0.050M solution of the group 13 reagent is added. After 10 min, 0.44 umol of the activator solution in toluene (5 mM) was added to the 1 mL vial. About another 60 seconds later, a fraction of the total 1 mL vial contents containing the indicated “catalyst amount injected” being identified in table 4 was injected into the prepressurized reaction vessel and was followed immediately by injection of toluene to increase the total volume injected of 0.400 mL. Method MM: An appropriate amount based on the equivalents presented in table 4 of a 0.020M solution of the group 13 reagent is dispensed into a 1 mL vial. 80 uL of a complex solution containing 0.4 umol metal complex (5 mM in toluene) is added. After 50 sec, an appropriate amount of the activator solution in toluene (“ABF20” is 2.5 mM and “BF15” is 5 mM), containing the indicated equivalents of “activator” (per mole isolated complex) in the specific examples in table 4, was added to the 1 mL vial. About another 60 seconds later a fraction of the total 1 mL vial contents containing the indicated “catalyst amount injected” being identified in table 4 was injected into the prepressurized reaction vessel and was followed immediately by injection of toluene to increase the total volume injected of 0.500 mL.

[0309] Polymerization and Product work up: The polymerization reaction and product work up were preformed in the manner described in Example 41.

5TABLE 4Group 13catalystreagentActivatoramountPolym.Polym.Activity (gMolecularMeltingcomplexationand moleand molActivationinjectedtemp.timepolymer/Crystallinityweight Mwpoint byComplexmethodequiv.equiv.methodnmol(Celsius)(sec)(min * mmol)index(k)DSCC1 5 TEAL1.1 ABF20MM2590802923330.6417C15 TIBA1.1 ABF20MM2590803453380.59574C15 MMAO1.1 ABF20MM2590803242810.61654C15 MMAO2.2 BF15MM25901204401340.61780C15 TEAL1.1 ABF20MM25110806001440.58228C15 TIBA1.1 ABF20MM25110804712150.56129C210 DIBAL1.1 ABF20LL251101001795710.78191C210 DIBAL1.1 ABF20LL5511010011011690.77121C210 TMA1.1 ABF20LL2511010060029ndndC210 TMA1.1 ABF20LL551101007721290.7984C210 TIBA1.1 ABF20LL55110100600480.79260C330 DIBAL1.1 ABF20JJ20110509937170.83165129C330 DIBAL1.1 ABF20JJ20130509033080.84118129C330 TIBA1.1 ABF20JJ20110509740130.82222C330 TIBA1.1 ABF20JJ20130509431770.83102C45 MMAO1.1 ABF20MM25908015710770.35527C45 PMAO1.1 ABF20MM25908014111940.35716C45 TIBA1.1 ABF20MM20908014012880.32520C45 MMAO2.2 BF15MM2590801579850.3734C45 MMAO1.1 ABF20MM25110801627170.36220C45 PMAO1.1 ABF20MM25110801666850.35292C530 DIBAL1.1 ABF20JJ201105017911870.87275147C530 DIBAL1.1 ABF20KK20130503186340.9113143C530 TIBA1.1 ABF20JJ201105015517070.91246C530 TIBA1.1 ABF20KK20130503914850.9247C610 DIBAL1.1 ABF20II201101002632190.9258C630 DIBAL1.1 ABF20JJ20130200900340.9314C630 TIBA1.1 ABF20JJ201101004871870.9567C630 TIBA1.1 ABF20JJ20130200900400.9318C730 DIBAL1.1 ABF20JJ201101008036360.79315C730 DIBAL1.1 ABF20JJ201302009001310.8219C710 TIBA1.1 ABF20II201101007335320.76175C730 TIBA1.1 ABF20JJ201302009001750.8274

Example 42

[0310] Ethylene-Styrene or Ethylene-1-Octene copolymerizations using metal-ligand compositions. A total of twelve (12) separate ethylene-1-octene copolymerization reactions were performed and thirty-nine (39) separate ethylene-styrene copolymerization reactions were performed as described herein:

[0311] Preparation of the polymerization reactor prior to injection of catalyst composition: A pre-weighed glass vial insert and disposable stirring paddle were fitted to each reaction vessel of the reactor. The reactor was then closed, 0.10 mL of a 0.02 M group 13 reagent solution in toluene and 3.8 mL of toluene were injected into each pressure reaction vessel through a valve. The identity of the group 13 reagent solution is MMAO. The temperature was then set to 110° C., and the stirring speed was set to 800 rpm, and the mixture was exposed to ethylene at 100 psi pressure. An ethylene pressure of 100 psi in the pressure cell and the temperature setting were maintained, using computer control, until the end of the polymerization experiment.

[0312] Preparation of the group 13 reagent and activator stock solutions: The “activator solution” is a 5 mM solution of N,N′-dimethylanilinium tetrakis (pentafluorophenyl) borate in toluene (“ABF20”). The solution is heated to approximately 85° C. to dissolve the reagent. The group 13 reagent solution is a solution of Modified Methylaluminoxane—3A (Azko) (“MMAO”) in toluene.

[0313] In situ preparation of metal-ligand compositions: The following method was employed to prepare the metal-ligand compositions as indicated in the table 5-6. Method K: An appropriate amount ligand solution (10 mM in toluene) was dispensed in a 1 mL glass vial at a scale of 0.4-0.75 mmol. To the 1 mL glass vial containing the ligand solution was added an equimolar amount of metal precursor solution (10 mM in toluene) to form the metal-ligand composition solution. The reaction mixture was heated to 70-80° C. for 45 min.

[0314] Activation methods and Injection of solutions into the pressure reactor vessel: The following methods were employed to activate and inject the metal-ligand compositions as indicated in the tables 5-6. Method EE: To the ligand metal composition (preparation described above), 20 equivalents (per metal precursor equivalent) of a 500 mM solution of 1-octene in toluene was added to the metal ligand composition in the 1 mL vial. Then, the indicated amount of the group 13 reagent solution (50 mM) was added to the 1 mL vial. This mixture was held at room temperature for 60-70 sec, during which time, 0.420 mL of comonomer (styrene or 1-octene) followed immediately by 0.380 mL of toluene, were injected into the prepressurized reaction vessel. Then, the appropriate amount of the “activator solution” (5 mM) was added to the 1 mL vial. After about 30-40 sec, a fraction of the 1 mL vial contents containing the indicated “catalyst amount injected” were injected into the reaction vessel and was followed immediately by injection of toluene to increase the total volume injected of 0.400-0.500 mL.

[0315] Polymerization: The polymerization reaction was allowed to continue for 60-600 seconds, during which time the temperature and pressure were maintained at their pre-set levels by computer control. The specific times for each polymerization are shown in tables 5-6. The polymerization times were the lesser of the maximum desired polymerization time or the time taken for a predetermined amount of monomer gas to be consumed in the polymerization reaction. After the reaction time elapsed, the reaction was quenched by addition of an overpressure of carbon dioxide sent to the reactor.

[0316] Product work up: ethylene/styrene or ethylene/1-octene copolymerizations After the polymerization reaction, the glass vial insert, containing the polymer product and solvent, was removed from the pressure cell and removed from the inert atmosphere dry box, and the volatile components were removed using a centrifuge vacuum evaporator. After substantial evaporation of the volatile components, the vial contents were dried thoroughly by evaporation at elevated temperature under reduced pressure. The vial was then weighed to determine the yield of polymer product. The polymer product was then analyzed by rapid GPC, as described above to determine the molecular weight of the polymer produced, and by FTIR or Raman spectroscopy to determine the comonomer incorporation. Results are presented in the Table 5 for ethylene-styrene copolymerizations and Table 6 for ethylene-1-octene copolymerizations.

6TABLE 5ActivityMol %Group 13catalyst(gStyreneMetalreagentActivatoracti-amountPolym.Polym.polymer/by mol %Mwpre-Comon-complexationand moleand molvationinjectedtemp. (time(min *linearstyrene(/1000)Ligandcursoromermethodequiv.equiv.methodnmolCelsius)(sec)mmol)regres.by PLS(PDI)LL46ZrBz4StyreneK6 MMAO1.1 ABF20EE13311017449712.2 5 (2.5)LL46HfBz4StyreneK6 MMAO1.1 ABF20EE13311013663514.6 3 (1.3)LL37ZrBz4StyreneK5 MMAO1.1 ABF20EE751109011629bimodalLL37HfBz4StyreneK5 MMAO1.1 ABF20EE751109012614.1bimodalLL48ZrBz4StyreneK5 MMAO1.1 ABF20EE1501103232271.7 36 (nd)LL48HfBz4StyreneK5 MMAO1.1 ABF20EE300110755472.7 342 (nd)LL31ZrBz4StyreneK5 MMAO1.1 ABF20EE751102546011 13 (1.6)LL31HfBz4StyreneK5 MMAO1.1 ABF20EE75110900582.4 544 (2.0)LL28ZrBz4StyreneK5 MMAO1.1 ABF20EE1501101278093.4 86 (nd)LL28HfBz4StyreneK5 MMAO1.1 ABF20EE3001102891805.8 209 (nd)LL29ZrBz4StyreneK5 MMAO1.1 ABF20EE7511014112731.9 26 (1.9)LL29HfBz4StyreneK5 MMAO1.1 ABF20EE751103754613.8194m(1.8)LL29TiBz4StyreneK5 MMAO1.1 ABF20EE200110600151.1 105 (5)LL30ZrBz4StyreneK5 MMAO1.1 ABF20EE7511015811721.9 105 (4.8)LL30HfBz4StyreneK5 MMAO1.1 ABF20EE75110604583.1 281 (2.0)LL38ZrBz4StyreneK5 MMAO1.1 ABF20EE7511010219061.3 26 (2.1)LL38HfBz4StyreneK5 MMAO1.1 ABF20EE751102697174.2 180 (2.2)LL39ZrBz4StyreneK5 MMAO1.1 ABF20EE751102954821.3broadLL39HfBz4StyreneK5 MMAO1.1 ABF20EE751109001402.3broadLL40ZrBz4StyreneK5 MMAO1.1 ABF20EE7511011218173.4 24 (2.0)LL40HfBz4StyreneK5 MMAO1.1 ABF20EE7511025990011.4 207 (1.9)LL32ZrBz4StyreneK5 MMAO1.1 ABF20EE751102635581.1 76 (3.9)LL32HfBz4StyreneK5 MMAO1.1 ABF20EE751105362692.3 251 (2.4)LL45ZrBz4StyreneK5 MMAO1.1 ABF20EE1501101784783.7 21LL45HfBz4StyreneK5 MMAO1.1 ABF20EE300110716594 209LL26ZrBz4StyreneK5 MMAO1.1 ABF20EE1501103971962.3 38LL26HfBz4StyreneK5 MMAO1.1 ABF20EE300110900310.9 181LL27ZrBz4StyreneK5 MMAO1.1 ABF20EE150110900580.9 195LL27HfBz4StyreneK5 MMAO1.1 ABF20EE300110900351.5 685LL33ZrBz4StyreneK5 MMAO1.1 ABF20EE751109001061 48 (2.4)LL33HfBz4StyreneK5 MMAO1.1 ABF20EE75110900951.4 307 (2.2)LL43ZrBz4StyreneK5 MMAO1.1 ABF20EE150110900651.8LL43HfBz4StyreneK5 MMAO1.1 ABF20EE300110900142LL1ZrBz4StyreneK5 MMAO1.1 ABF20EE751108961502.41346 (1.6)LL1HfBz4StyreneK5 MMAO1.1 ABF20EE751109011123.6 885 (1.9)LL4ZrBz4StyreneK5 MMAO1.1 ABF20EE751106001844.11165 (1.9)LL4HfBz4StyreneK5 MMAO1.1 ABF20EE501106003078notdissolvedLL7ZrBz4StyreneK5 MMAO1.1 ABF20EE751106001663 872 (1.4)LL7HfBz4StyreneK5 MMAO1.1 ABF20EE501106001472.91732 (1.5)

[0317]

7

TABLE 6

Group 13

catalyst

Activity
Mol %

Metal

reagent
Activator
acti-
amount
Polym.
Polym.
(g polymer/
Octene
Mw

pre-

complexation
and mole
and mol
vation
injected
temp.
time
(min *
by
(/1000)

Ligand
cursor
Comonomer
method
equiv.
equiv.
method
nmol
(Celsius)
(sec)
mmol)
Raman
(PDI)

LL7
TiBz4
C8
K
5 MMAO
1.1 ABF20
EE
200
110
600
32
8
2380 (1.4)

LL7
ZrBz4
C8
K
5 MMAO
1.1 ABF20
EE
75
110
369
678
17
679 (2.3)

LL7
HfBz4
C8
K
5 MMAO
1.1 ABF20
EE
50
110
600
553
28
641 (4.1)

LL4
TiBz4
C8
K
5 MMAO
1.1 ABF20
EE
200
110
600
36
8
1341 (1.6)

LL4
ZrBz4
C8
K
5 MMAO
1.1 ABF20
EE
75
110
198
1251
19
488 (2.3)

LL4
HfBz4
C8
K
5 MMAO
1.1 ABF20
EE
50
110
431
822
27
1706 (3.4)

LL38
TiBz4
C8
K
5 MMAO
1.1 ABF20
EE
200
110
600
84
6
170 (3.7)

LL38
ZrBz4
C8
K
5 MMAO
1.1 ABF20
EE
75
110
61
4378
12
37 (2.0)

LL38
HfBz4
C8
K
5 MMAO
1.1 ABF20
EE
50
110
113
2852
15
93 (1.9)

LL40
TiBz4
C8
K
5 MMAO
1.1 ABF20
EE
200
110
403
148
10
151 (4.8)

LL40
ZrBz4
C8
K
5 MMAO
1.1 ABF20
EE
75
110
60
4425
15
12 (1.9)

LL40
HfBz4
C8
K
5 MMAO
1.1 ABF20
EE
50
110
107
3686
17
99 (2.2)

[0318] It is to be understood that the above description is intended to be illustrative and not restrictive. Many embodiments will be apparent to those of skill in the art upon reading the above description. The scope of the invention should, therefore, be determined not with reference to the above description, but should instead be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. The disclosures of all articles and references, including patent applications and publications, are incorporated herein by reference for all purposes.

Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

US Classifications

International Classifications

Abstract

Description

Claims

Parent Case Info

Provisional Applications (1)